https://curecurrent.com/trials/vildagliptin-versus-dapagliflozin-on-glucagon-18001https://curecurrent.com/trials/postpartum-screening-of-type-2-diabetes-18002https://curecurrent.com/trials/screening-type-2-diabetes-mellitus-on-the-2nd-day-after-delivery-in-women-with-gestational-diabetes-mellitus-18003https://curecurrent.com/trials/clinical-and-economic-benefits-of-cardiovascular-risk-management-by-a-dietician-in-type-2-diabetes-patients-18004https://curecurrent.com/trials/comparing-pharmacodynamic-and-pharmacokinetic-properties-of-insulin-degludec-and-insulin-glargine-300-u-ml-at-steady-sta-18005https://curecurrent.com/trials/the-effects-of-coffee-main-constituents-caffeine-and-chlorogenic-acid-supplementation-on-inflammatory-metabolic-factors-18006https://curecurrent.com/trials/effects-of-glucose-fluctuation-intervention-on-the-prognosis-of-patients-with-type-2-diabetes-and-cerebral-infarction-18007https://curecurrent.com/trials/investigation-of-the-effect-of-upper-gastrointestinal-disease-on-the-pharmacokinetics-of-oral-semaglutide-in-subjects-wi-18008https://curecurrent.com/trials/feasibility-of-a-preventive-program-against-lifestyle-related-diseases-18009https://curecurrent.com/trials/diabetes-foot-care-clinical-pathway-project-exciton-technologies-inc-18010https://curecurrent.com/trials/preventing-diabetic-osteoporosis-with-exercise-18011https://curecurrent.com/trials/predictability-of-gestational-diabetes-mellitus-in-first-and-second-trimester-18012https://curecurrent.com/trials/efficacy-security-adherence-tolerability-and-cost-effectiveness-of-latent-tb-treatment-in-patients-with-tb-dm2-tbl-18013https://curecurrent.com/trials/yoghurt-consumption-body-weight-management-and-glycemic-control-of-t2dm-patients-18014https://curecurrent.com/trials/increasing-dr-screening-through-top-supporting-implementation-and-identifying-opportunities-for-scale-up-in-ontario-18015https://curecurrent.com/trials/videolaryngoscopy-for-intubation-in-patients-with-diabetes-18016https://curecurrent.com/trials/effect-of-meal-frequency-and-timing-on-insulin-dose-and-clock-gene-in-type-2-diabetic-patients-18017https://curecurrent.com/trials/cooking-classes-for-chinese-canadian-patients-living-with-diabetes-18018https://curecurrent.com/trials/patients-with-diabetic-neuropathy-who-receive-physiotherapy-treatment-will-have-a-decrease-in-diabetic-foot-ulcers-18019https://curecurrent.com/trials/study-of-diabetic-nephropathy-with-atrasentan-18020https://curecurrent.com/trials/does-the-advice-to-eat-a-mediterranean-diet-with-low-carbohydrate-intake-compared-with-a-low-fat-diet-reduce-diabetes-an-18021https://curecurrent.com/trials/exercise-as-cardio-protective-modulates-in-diabetic-patients-18022https://curecurrent.com/trials/impact-of-p53-and-sirt1-in-type-2-diabetes-18023https://curecurrent.com/trials/s-texas-hope-family-health-center-18024https://curecurrent.com/trials/prognosis-of-type-2-diabetic-patients-18025https://curecurrent.com/trials/medical-nutrition-therapy-intervention-program-for-women-with-gestational-diabetes-a-prospective-study-18026https://curecurrent.com/trials/non-interventional-study-of-the-use-of-alogliptin-and-alogliptin-fixed-dose-combinations-with-pioglitazone-and-with-metf-18027https://curecurrent.com/trials/evaluation-of-the-tubular-effects-of-dapagliflozin-using-1hnmr-spectroscopy-18028https://curecurrent.com/trials/the-effect-of-midazolam-premedication-on-copeptine-concentration-in-blood-18029https://curecurrent.com/trials/kuopio-ischaemic-heart-disease-risk-factor-study-nutrition-component-18030https://curecurrent.com/trials/pulmonary-tuberculosis-patients-with-diabetes-mellitus-18031https://curecurrent.com/trials/obesity-related-health-benefits-of-apples-18032https://curecurrent.com/trials/induction-of-labour-for-lga-f-tus-in-women-without-insulin-treated-diabetes-18033https://curecurrent.com/trials/prebiotic-fiber-supplement-in-t1dm-children-18034https://curecurrent.com/trials/breaking-up-sitting-with-a-treadmill-desk-in-office-workers-18035https://curecurrent.com/trials/diabetes-in-sindhi-families-in-nagpur-disfin-18036https://curecurrent.com/trials/effect-of-oral-supplementation-with-curcumin-on-insulin-sensitivity-in-subjects-with-prediabetes-18037https://curecurrent.com/trials/heart-rate-during-exercise-in-type-2-diabetes-18038https://curecurrent.com/trials/study-of-da-9801-to-treat-diabetic-neuropathic-pain-18039https://curecurrent.com/trials/clinical-study-of-adipose-derived-stem-cells-in-the-treatment-of-diabetic-foot-18040https://curecurrent.com/trials/endobarrier-tm-gastrointestinal-liner-diabetes-trial-18041https://curecurrent.com/trials/a-trial-to-assess-a-co-formulation-of-an-insulin-analog-and-pramlintide-in-subjects-with-type-1-diabetes-mellitus-18042https://curecurrent.com/trials/maternal-gdm-in-hispanic-youth-risk-for-obesity-18043https://curecurrent.com/trials/prevention-of-gestational-diabetes-through-lifestyle-modification-18044https://curecurrent.com/trials/efficacy-of-linolenic-acid-and-thioctic-acid-in-patients-with-diabetic-neuropathy-18045https://curecurrent.com/trials/long-term-effects-of-lifestyle-intervention-during-pregnancy-in-high-risk-women-and-in-their-offspring-role-of-environme-18046https://curecurrent.com/trials/changes-in-the-diameter-of-retinal-vessels-after-remote-ischemic-conditioning-in-patients-with-type-1-diabetes-18047https://curecurrent.com/trials/diabetic-foot-ulcer-study-on-topical-interventions-18048https://curecurrent.com/trials/can-mcpn-intervention-improve-injection-site-rotation-18049https://curecurrent.com/trials/predictors-of-skin-temperature-plantar-pressure-and-ulceration-in-diabetic-foot-patients-18050https://curecurrent.com/trials/a-study-for-sufficient-acarbose-decreased-glucose-excursion-in-type-2-diabetic-patients-18051https://curecurrent.com/trials/effect-of-training-intensity-on-health-outcomes-in-diabetes-18052https://curecurrent.com/trials/interventional-study-of-active-weight-management-in-patients-with-type-2-diabetes-and-obesity-in-routine-clinical-practi-18053https://curecurrent.com/trials/aerobic-training-in-post-mi-patients-with-dpn-18054https://curecurrent.com/trials/the-safety-and-efficacy-of-dapagliflozin-therapy-in-combination-with-insulin-in-japanese-subjects-with-t1dm-18055https://curecurrent.com/trials/blood-glucose-response-after-oral-intake-of-lactulose-in-mildly-constipated-patients-with-diabetes-mellitus-type-2-18056https://curecurrent.com/trials/neuropathic-pain-in-elderly-people-with-diabetes-impact-on-quality-of-life-and-cognition-18057https://curecurrent.com/trials/serum-copeptin-as-a-predictor-of-the-risk-of-hyponatremia-after-transurethral-prostatectomy-18058https://curecurrent.com/trials/real-world-diagnostic-effectiveness-of-artificial-intelligence-algorithm-in-diabetic-retinopathy-screening-18059https://curecurrent.com/trials/nutritional-safety-and-metabolic-benefits-of-oncometabolic-surgery-for-obese-gastric-cancer-patients-18060https://curecurrent.com/trials/efficacy-of-wharton-jelly-in-erectile-dysfunction-18061https://curecurrent.com/trials/effects-of-short-term-intensive-insulin-therapy-on-long-term-complications-in-type-2-diabetes-18062https://curecurrent.com/trials/ultrasound-evaluation-of-gastric-emptying-in-diabetic-patients-a-comparison-with-non-diabetic-controls-18063https://curecurrent.com/trials/metformin-and-its-effects-on-left-ventricular-hypertrophy-in-normotensive-patients-with-coronary-artery-disease-18064https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-drug-drug-interaction-of-evogliptin-and-empagliflozin-or-dapagliflozin-in-healthy-ma-18065https://curecurrent.com/trials/safety-and-efficacy-of-resticutis-compared-to-platelet-poor-plasma-for-treating-diabetic-foot-ulcers-18066https://curecurrent.com/trials/expanding-paramedicine-in-the-community-18067https://curecurrent.com/trials/evaluation-of-hba1c-levels-and-ovarian-reserve-and-type-1-diabetes-18068https://curecurrent.com/trials/serum-hs-crp-in-periodontitis-patients-with-or-without-diabetes-18069https://curecurrent.com/trials/phase-i-study-of-continuous-administration-of-salvianolic-acid-a-tablet-18070https://curecurrent.com/trials/lavender-aromatherapy-on-sleep-quality-and-metabolic-parameters-of-type-2-diabetic-patients-with-insomnia-18071https://curecurrent.com/trials/motivational-interviewing-and-self-care-in-type-1-diabetes-randomized-controlled-clinical-trial-18072https://curecurrent.com/trials/melatonin-s-effects-on-treatment-of-diabetes-mellitus-18073https://curecurrent.com/trials/a-multiple-ascending-dose-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-pk-of-medi0382-in-overweight-and-ob-18074https://curecurrent.com/trials/assessment-of-myocardial-injury-in-simultaneous-pancreas-and-kidney-transplantation-18075https://curecurrent.com/trials/the-effects-of-immersion-in-dead-sea-water-on-glucose-levels-in-type-2-diabetes-mellitus-patients-18076https://curecurrent.com/trials/information-and-communication-technology-based-centralized-clinical-trial-monitoring-system-for-insulin-dose-adjustment-18077https://curecurrent.com/trials/influence-of-probiotics-in-diabetic-cardiopathies-with-excessive-weight-18078https://curecurrent.com/trials/etdrs-prp-with-ivr-versus-retinal-photocoagulation-targeted-to-ischemic-retina-with-ivr-for-the-treatment-of-pdr-18079https://curecurrent.com/trials/a-study-to-evaluate-the-performance-of-vibratip-by-different-clinical-users-18080https://curecurrent.com/trials/acticoat-for-the-treatment-of-burns-and-chronic-wounds-18081https://curecurrent.com/trials/a-systematic-study-of-retinal-structure-and-function-in-diabetic-macular-oedema-18082https://curecurrent.com/trials/short-term-effect-of-pomegranate-juice-on-blood-sugar-and-its-controlling-hormones-in-pre-diabetic-and-type-ii-diabetic-18083https://curecurrent.com/trials/effect-of-testosterone-on-endothelial-function-and-microcirculation-in-type-2-diabetic-patients-with-hypogonadism-18084https://curecurrent.com/trials/comparison-of-aurora-fundus-camera-with-traditional-camera-in-diabetic-retinopathy-with-visual-artificial-intelligence-18085https://curecurrent.com/trials/intensified-multifactorial-intervention-in-patients-with-type-2-diabetes-and-microalbuminuria-18086https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-of-two-drugs-vildagliptin-and-metformin-in-patients-with-type-2-diabetes-mellitus-18087https://curecurrent.com/trials/comparing-efficacy-and-safety-of-insulin-degludec-insulin-aspart-and-biasp-30-in-subjects-with-type-2-diabetes-18088https://curecurrent.com/trials/a-clinical-trial-assessing-the-impact-of-inhaled-insulin-on-glucose-control-in-patients-with-type-2-diabetes-mellitus-18089https://curecurrent.com/trials/comparison-of-hematopoietic-stem-cell-activity-in-adipose-tissue-from-type-2-diabetic-patients-and-healthy-volunteers-18090https://curecurrent.com/trials/the-effect-of-morning-versus-evening-administration-on-the-pharmacokinetics-and-pharmacodynamics-of-empagliflozin-18091https://curecurrent.com/trials/activation-innate-immune-system-in-type-1-diabetes-18092https://curecurrent.com/trials/ertugliflozin-vs-glimepiride-in-type-2-diabetes-mellitus-t2dm-participants-on-metformin-mk-8835-002-18093https://curecurrent.com/trials/long-term-resveratrol-and-metabolism-18094https://curecurrent.com/trials/multi-modal-imaging-and-artificial-intelligence-diagnostic-system-for-multi-level-clinical-application-18095https://curecurrent.com/trials/effectiveness-of-automated-mobile-phone-based-text-messaging-on-the-improvement-of-glycaemic-outcomes-18096https://curecurrent.com/trials/the-guardcontrol-trial-study-to-assess-if-type-1-diabetics-can-improve-using-the-real-time-values-of-guardian-rt-18097https://curecurrent.com/trials/intergenerational-programming-of-diabesity-in-offspring-of-women-with-gestational-diabetes-mellitus-18098https://curecurrent.com/trials/extra-virgin-olive-oil-on-glycemic-control-insulin-resistance-and-insulin-secretion-18099https://curecurrent.com/trials/a-research-study-of-how-faster-acting-insulin-aspart-moves-into-through-and-out-of-the-body-and-how-it-works-in-the-body-18100https://curecurrent.com/trials/the-pk-characteristics-of-the-co-administration-of-metformin-sr-and-rosuvastatin-and-jlp-1310-in-healthy-male-volunteers-18101https://curecurrent.com/trials/extended-wear-of-a-steel-and-a-teflon-insulin-infusion-set-18102https://curecurrent.com/trials/pre-visit-prioritization-for-complex-patients-with-diabetes-18103https://curecurrent.com/trials/implementation-of-a-very-low-calorie-diet-for-remission-of-type-2-diabetes-in-the-community-18104https://curecurrent.com/trials/efficacy-and-safety-study-of-empagliflozin-as-add-on-to-insulin-in-japanese-patients-with-type-2-diabetes-mellitus-18105https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-and-dapagliflozin-plus-saxagliptin-in-combination-with-metformin-in-type-2-diabetes-18106https://curecurrent.com/trials/a-trial-comparing-efficacy-and-safety-of-insulin-degludec-insulin-aspart-and-biasp-30-in-insulin-na-ve-subjects-with-typ-18107https://curecurrent.com/trials/metabolic-surgery-gastric-bypass-vs-sleeve-gastrectomy-efects-over-type-2-dm-with-bad-metabolic-control-mso1ct-18108https://curecurrent.com/trials/efficacy-of-platelets-rich-plasma-as-a-therapeutic-tool-in-diabetic-foot-ulcers-18109https://curecurrent.com/trials/multi-modal-intervention-in-frail-and-prefrail-older-people-with-type-2-diabetes-18110https://curecurrent.com/trials/effect-of-monitoring-of-step-number-on-diabetes-18111https://curecurrent.com/trials/the-comunicare-study-the-effectiveness-of-a-multimodal-intervention-based-on-person-centered-communication-18112https://curecurrent.com/trials/effect-of-an-electronic-reminder-system-on-direct-oral-anticoagulant-and-oral-diabetes-medication-adherence-18113https://curecurrent.com/trials/structured-education-based-on-new-glucose-management-devices-in-patients-with-type-1-diabetes-mellitus-18114https://curecurrent.com/trials/metformin-and-sitagliptin-in-women-with-previous-gestational-diabetes-18115https://curecurrent.com/trials/efficacy-of-tdna-care-on-weight-loss-and-metabolic-outcomes-in-patients-with-overweight-obesity-and-type-2-diabetes-18116https://curecurrent.com/trials/a-single-dose-trial-to-investigate-the-safety-and-tolerability-of-xen-d0501-in-patients-with-diabetes-mellitus-type-2-18117https://curecurrent.com/trials/glucocorticoids-and-skin-healing-in-diabetes-gc-sheald-18118https://curecurrent.com/trials/sglt2-inhibition-and-left-ventricular-mass-18119https://curecurrent.com/trials/optimal-growth-of-preterm-infants-with-growth-restriction-18120https://curecurrent.com/trials/cocarnit-effects-on-macrophages-polarization-18121https://curecurrent.com/trials/azilsaltan-tablets-azilva-tablets-special-drug-use-surveillance-hypertension-complicated-by-diabetes-18122https://curecurrent.com/trials/platelet-inhibition-of-ticagrelor-versus-clopidogrel-in-type-2-diabetic-patients-after-elective-percutaneous-coronary-in-18123https://curecurrent.com/trials/safety-and-efficacy-study-to-compare-vildagliptin-to-pioglitazone-as-adding-on-metformin-in-type-2-diabetes-18124https://curecurrent.com/trials/comparison-of-cardiovascular-outcomes-of-pioglitazone-and-metformin-in-type-2-diabetes-patients-18125https://curecurrent.com/trials/health-promoting-lifestyle-education-on-women-with-gestational-diabetes-mellitus-18126https://curecurrent.com/trials/effect-of-diet-and-physical-activity-on-incidence-of-type-2-diabetes-18127https://curecurrent.com/trials/using-pharmacogenetics-to-improve-treatment-in-early-onset-diabetes-18128https://curecurrent.com/trials/relation-between-cachexia-diabetes-and-perineural-invasion-in-pancreatic-cancer-biomarkers-substudy-18129https://curecurrent.com/trials/effects-of-nitrate-on-liver-perfusion-and-sugar-control-18130https://curecurrent.com/trials/the-effect-of-dietary-nitrate-supplementation-on-ability-of-individuals-with-type-2-diabetes-to-perform-exercise-18131https://curecurrent.com/trials/topical-erythropoietin-hydrogel-formulation-for-diabetic-foot-ulcers-18132https://curecurrent.com/trials/reverse-colocated-integrated-care-intervention-among-persons-with-severe-persistent-mental-illness-at-us-mexico-border-18133https://curecurrent.com/trials/role-of-new-adipokines-and-hepatokines-in-prediction-of-patients-with-metabolic-syndrome-or-nafld-18134https://curecurrent.com/trials/reproducibility-of-glucose-fluctuations-by-standardized-exercise-for-patients-with-type-1-diabetes-a-method-study-based-18135https://curecurrent.com/trials/prevention-of-diabetes-mellitus-development-in-women-who-had-already-experienced-a-gestational-diabetes-18136https://curecurrent.com/trials/therapeutic-efficacy-of-triple-combination-in-drug-na-ve-korean-type-2-diabetic-patients-18137https://curecurrent.com/trials/trial-to-compare-nnc0123-0000-0338-in-a-tablet-formulation-and-insulin-glargine-in-subjects-with-type-2-diabetes-current-18138https://curecurrent.com/trials/a-study-of-ly2605541-and-glargine-and-exercise-in-participants-with-type-1-diabetes-18139https://curecurrent.com/trials/a-study-comparing-insulin-peglispro-with-insulin-glargine-as-basal-insulin-treatment-18140https://curecurrent.com/trials/chlorhexidine-gluconate-solution-at-0-125-vs-placebo-for-the-healing-of-grade-iib-ulcers-of-diabetic-foot-18141https://curecurrent.com/trials/empagliflozin-in-renal-transplant-recipients-18142https://curecurrent.com/trials/teleconsultation-in-type-1-diabetes-mellitus-18143https://curecurrent.com/trials/glucose-monitoring-during-threatening-preterm-birth-in-patients-with-and-without-gestational-diabetes-mellitus-18144https://curecurrent.com/trials/efficacy-and-safety-of-voglibose-compared-with-acarbose-in-participants-with-type-2-diabetes-18145https://curecurrent.com/trials/exercise-effects-on-appetite-regulating-hormones-and-cardiovascular-risk-factors-18146https://curecurrent.com/trials/implementing-and-testing-a-cardiovascular-assessment-screening-program-casp-18147https://curecurrent.com/trials/three-dimensional-measurements-of-diabetic-foot-ulcers-18148https://curecurrent.com/trials/pioglitazone-tablets-special-drug-use-surveillance-combined-use-of-insulin-products-long-term-treatment-18149https://curecurrent.com/trials/pharmacokinetics-and-safety-tolerability-after-oral-administration-of-ckd-370-and-d745-in-healthy-adults-18150https://curecurrent.com/trials/evaluation-of-a-community-health-program-for-the-prevention-of-type-2-diabetes-and-other-cardio-metabolic-risk-factors-i-18151https://curecurrent.com/trials/effect-of-glp-1-analogs-on-psoriasis-in-type-2-diabetic-patients-18152https://curecurrent.com/trials/surgical-treatment-of-periimplantitis-in-patients-with-risk-factors-18153https://curecurrent.com/trials/a-study-of-insulin-peglispro-and-glargine-on-fats-in-participants-with-type-1-diabetes-18154https://curecurrent.com/trials/a-survey-on-low-blod-sugar-among-insulin-treated-patients-with-diabetes-18155https://curecurrent.com/trials/be-study-of-bilayer-combination-of-gemigliptin-rosuvastatin-50-20mg-in-comparison-to-monolayer-combination-18156https://curecurrent.com/trials/a-user-performance-and-system-use-evaluation-of-a-new-blood-glucose-monitoring-system-bgms-18157https://curecurrent.com/trials/spectrophon-ltd-glucometry-monitor-accuracy-18158https://curecurrent.com/trials/ugandan-non-communicable-diseases-and-aging-cohort-18159https://curecurrent.com/trials/the-effects-of-ly2409021-on-the-liver-18160https://curecurrent.com/trials/effects-of-standardized-meals-on-the-metabolic-hormonal-and-inflammatory-responses-in-human-18161https://curecurrent.com/trials/the-clinical-trial-to-investigate-the-pharmacokinetics-and-safety-tolerability-of-ckd-375-18162https://curecurrent.com/trials/lifestyle-changes-and-glycemic-control-in-t1d-18163https://curecurrent.com/trials/a-study-of-ly2605541-insulin-peglispro-and-human-insulin-concentrations-in-fat-tissue-18164https://curecurrent.com/trials/joints-mobilization-versus-myofascial-release-on-diabetic-patients-with-painful-heel-18165https://curecurrent.com/trials/prp-vs-prp-ivc-for-severe-npdr-18166https://curecurrent.com/trials/low-dose-ticagrelor-versus-low-dose-prasugrel-in-patients-with-prior-myocardial-infarction-18167https://curecurrent.com/trials/the-skills-confidence-preparedness-index-scpi-18168https://curecurrent.com/trials/ngf-trka-p75ntr-in-men-with-ed-and-diabetes-with-or-without-ms-18169https://curecurrent.com/trials/vascular-markers-during-ogtt-in-diabetics-and-first-degree-relatives-18170https://curecurrent.com/trials/usage-of-dapagliflozin-in-the-management-of-type-2-diabetes-mellitus-a-real-world-evidence-study-in-indian-patients-18171https://curecurrent.com/trials/web-based-support-during-pregnancy-and-early-motherhood-in-women-with-type-1-diabetes-modiab-web-18172https://curecurrent.com/trials/population-research-of-sublingual-microcirculation-data-of-patients-with-systemic-diseases-18173https://curecurrent.com/trials/azilsartan-medoxomil-in-the-treatment-of-essential-hypertension-and-type-2-diabetes-in-asia-18174https://curecurrent.com/trials/dairy-products-diabetes-and-genetics-18175https://curecurrent.com/trials/priming-exercise-in-type-1-diabetes-18176https://curecurrent.com/trials/the-efficacy-of-bariatric-surgery-compared-to-medical-therapy-in-controlling-type2-diabetes-mellitus-in-patients-with-no-18177https://curecurrent.com/trials/a-study-to-compare-and-measure-the-effects-of-insulin-peglispro-ly2605541-and-glargine-on-meal-time-insulin-requirements-18178https://curecurrent.com/trials/to-compare-the-effects-of-non-nutritive-sweeteners-intake-in-subjects-with-t2dm-18179https://curecurrent.com/trials/adjunctive-hyperbaric-oxygen-therapy-hbot-for-lower-extermity-diabetic-ulcer-18180https://curecurrent.com/trials/effect-of-cpap-on-myocardial-dysfunction-in-type-2-diabetes-mellitus-and-obstructive-sleep-apnea-patients-18181https://curecurrent.com/trials/investigation-of-the-rewarming-og-the-fingers-after-cooling-and-the-autonomic-nervous-system-in-raynaud-s-phenomenon-18182https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-sitagliptin-addition-during-metformin-up-titration-mk-0431-848-18183https://curecurrent.com/trials/immune-profile-in-subjects-with-new-onset-type-1-diabetes-18184https://curecurrent.com/trials/a-pilot-study-to-assess-the-efficacy-of-neox-cord-1k-in-the-treatment-of-complex-diabetic-wounds-18185https://curecurrent.com/trials/gestational-diabetes-in-central-asia-prevalence-and-management-18186https://curecurrent.com/trials/potentially-avoidable-hospitalisation-in-france-18187https://curecurrent.com/trials/study-to-explore-the-effects-of-probiotics-on-endotoxin-levels-in-type-2-diabetes-mellitus-patients-18188https://curecurrent.com/trials/decoding-study-dermal-electrochemical-conductance-in-diabetic-neuropathy-18189https://curecurrent.com/trials/routine-use-of-sensor-augmented-pump-therapy-a-follow-up-study-18190https://curecurrent.com/trials/risk-of-nocturnal-hypoglycemia-and-arrhythmias-with-sitagliptin-versus-glimepiride-in-patients-with-type-2-diabetes-18191https://curecurrent.com/trials/institut-fuer-diabetes-technologie-surveillance-program-18192https://curecurrent.com/trials/retrospective-study-of-patients-with-type-2-diabetes-mellitus-on-dapagliflozin-therapy-in-taiwan-18193https://curecurrent.com/trials/curcumin-supplementation-and-patients-with-type-2-diabetes-18194https://curecurrent.com/trials/effectiveness-of-phone-calls-intervention-on-diabetic-patients-after-ambulatory-discharge-of-a-tertiary-care-center-18195https://curecurrent.com/trials/randomized-sitagliptin-withdrawal-study-mk-0431-845-18196https://curecurrent.com/trials/genetical-background-of-non-alcoholic-fatty-liver-disease-nafld-in-diabetes-mellitus-and-in-chronic-kidney-disease-18197https://curecurrent.com/trials/behavior-of-biomarkers-during-pregnancy-and-lactation-through-a-biological-multi-paradigm-model-become-study-protocol-18198https://curecurrent.com/trials/cardiovascular-risk-assesment-in-diabetic-patients-via-lens-autofluorecscence-detection-18199https://curecurrent.com/trials/zinc-supplementation-in-patients-with-thalassemia-major-complicated-with-diabetes-mellitus-18200https://curecurrent.com/trials/a-dose-finding-efficacy-and-safety-study-of-yy-351-in-patients-with-type-2-diabetes-18201https://curecurrent.com/trials/teneligliptin-versus-linagliptin-in-diabetes-mellitus-type-two-patients-18202https://curecurrent.com/trials/the-effect-of-prednisone-on-atherogenesis-as-studied-in-the-macrophage-foam-cell-formation-model-system-18203https://curecurrent.com/trials/pharmacokinetics-and-safety-tolerability-after-oral-administration-of-ckd-387-and-d635-under-fed-condition-18204https://curecurrent.com/trials/pharmacokinetics-and-safety-tolerability-after-oral-administration-of-ckd-387-and-d635-in-healthy-adults-18205https://curecurrent.com/trials/bioequivalence-study-of-empagliflozin-tablet-in-healthy-participants-18206https://curecurrent.com/trials/a-trial-to-investigate-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-biochaperone-pramlintide-insulin-in-18207https://curecurrent.com/trials/carelink-connect-technical-evaluation-study-18208https://curecurrent.com/trials/the-clinical-trial-to-investigate-the-pharmacokinetics-and-safety-tolerability-of-ckd-387-under-fed-condition-18209https://curecurrent.com/trials/the-rates-of-overtreatment-and-deintensification-in-patients-with-diabetes-mellitus-18210https://curecurrent.com/trials/the-effects-of-glycine-on-atherosclerosis-and-metabolic-syndrome-related-parameters-18211https://curecurrent.com/trials/development-of-pre-pregnancy-intervention-to-reduce-the-risk-of-diabetes-and-prediabetes-18212https://curecurrent.com/trials/health-outcomes-of-teens-participating-in-summer-employment-immersion-programs-18213https://curecurrent.com/trials/assessments-and-interventions-for-hand-neuropathy-in-dm-18214https://curecurrent.com/trials/measuring-and-monitoring-blood-glucose-levels-utilizing-non-invasive-blood-glucose-monitoring-device-18215https://curecurrent.com/trials/randomized-comparison-of-laparoscopic-sleeve-gastrectomy-and-gastric-bypass-for-morbid-obesity-18216https://curecurrent.com/trials/green-tea-extract-on-soluble-rage-in-patients-with-diabetic-nephropathy-18217https://curecurrent.com/trials/effects-of-ketone-bodies-on-cognition-in-type-2-diabetes-18218https://curecurrent.com/trials/sitagliptin-and-glucagon-counterregulation-18219https://curecurrent.com/trials/interpret-international-report-on-routine-practice-of-sensor-enabled-pump-therapy-18220https://curecurrent.com/trials/tongji-ezhou-study-18221https://curecurrent.com/trials/continuous-tart-cherry-juice-supplementation-with-metabolic-syndrome-participants-18222https://curecurrent.com/trials/vascular-protective-effect-of-rosuvastatin-in-arteriovenous-fistula-18223https://curecurrent.com/trials/insulin-therapy-for-the-prevention-of-new-onset-diabetes-after-transplantation-prospective-study-in-non-diabetic-de-novo-18224https://curecurrent.com/trials/effect-of-renal-impairment-on-the-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-ertugliflozin-in-particip-18225https://curecurrent.com/trials/high-fat-overfeeding-hepatokines-and-appetite-regulation-18226https://curecurrent.com/trials/trial-to-evaluate-the-efficacy-on-glycemic-variability-and-safety-of-gemigliptin-compared-with-dapagliflozin-added-on-me-18227https://curecurrent.com/trials/blood-urine-markers-for-drug-discovery-for-renal-disease-in-diabetes-18228https://curecurrent.com/trials/empagliflozin-add-on-to-linagliptin-study-in-japanese-patient-with-type-2-diabetes-mellitus-18229https://curecurrent.com/trials/maternal-weight-gain-in-gestational-diabetes-controlled-by-metformin-versus-insulin-18230https://curecurrent.com/trials/type-2-diabetes-risk-perceptions-and-self-management-behaviour-18231https://curecurrent.com/trials/vitamin-c-and-liraglutide-effects-on-hypoglycemia-induced-oxidative-stress-inflammation-and-endothelial-dysfunction-in-t-18232https://curecurrent.com/trials/metformin-in-pregnant-pcos-women-18233https://curecurrent.com/trials/integra-study-primary-care-intervention-in-type-2-diabetes-patients-with-poor-glycaemic-control-18234https://curecurrent.com/trials/an-exploratory-study-of-ds-8500a-on-beta-cell-function-using-hyperglycemic-clamp-18235https://curecurrent.com/trials/phase-2-study-of-ds-8500a-in-patients-with-type-2-diabetes-18236https://curecurrent.com/trials/a-pilot-study-on-effect-of-sky-on-psychosocial-parameters-of-type-2-diabetic-patients-after-a-6-days-18237https://curecurrent.com/trials/a-study-of-ds-8500a-in-japanese-subjects-with-type-2-diabetes-mellitus-receiving-sitagliptin-18238https://curecurrent.com/trials/smartphone-application-for-the-management-of-gestational-diabetes-mellitus-18239https://curecurrent.com/trials/empagliflozin-as-a-modulator-of-systemic-vascular-resistance-and-cardiac-output-in-patients-with-type-2-diabetes-18240https://curecurrent.com/trials/a-phase-2-study-of-ds-8500a-in-japanese-subjects-with-type-2-diabetes-mellitus-t2dm-18241https://curecurrent.com/trials/flexible-insulin-therapy-untethered-insulin-regimen-in-avidly-exercising-patients-with-type-1-diabetes-fit-untethered-18242https://curecurrent.com/trials/a-study-on-the-efficacy-and-gut-microbiota-of-berberine-and-probiotics-in-patients-with-newly-diagnosed-type-2-diabetes-18243https://curecurrent.com/trials/multifactorial-pre-operative-intervention-in-diabetes-mellitus-18244https://curecurrent.com/trials/effect-of-pistachio-intake-on-insulin-resistance-and-type-2-diabetes-mellitus-18245https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-during-postprandial-exercise-in-adults-with-type-1-diabetes-18246https://curecurrent.com/trials/the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonism-on-diabetic-kidney-disease-18247https://curecurrent.com/trials/the-practical-evidence-of-antidiabetic-combination-therapy-in-korea-18248https://curecurrent.com/trials/polyneuropathy-in-diabetes-mellitus-type-2-18249https://curecurrent.com/trials/daily-oral-l-arginine-plus-tadalafil-in-diabetic-patients-with-erectile-dysfunction-18250https://curecurrent.com/trials/nottingham-community-liver-biomarkers-cohort-18251https://curecurrent.com/trials/a-study-to-compare-insulin-intensification-of-biphasic-insulin-aspart-30-and-insulin-analogues-insulin-glargine-and-insu-18252https://curecurrent.com/trials/personalized-nutrition-for-diabetes-type-2-18253https://curecurrent.com/trials/pentoxifylline-effect-in-patients-with-diabetic-nephropathy-penfosidine-study-18254https://curecurrent.com/trials/a-study-of-the-usefulness-usability-of-a-healthcare-it-system-for-managing-multi-morbidity-and-poly-pharmacy-18255https://curecurrent.com/trials/analysis-of-markers-in-the-blood-correlated-with-neuropathic-pain-18256https://curecurrent.com/trials/comparing-efficacy-and-safety-of-cinnagen-liraglutide-versus-victoza-in-patients-with-type-ii-diabetes-18257https://curecurrent.com/trials/shenzhen-birth-cohort-study-18258https://curecurrent.com/trials/stem-cell-educator-therapy-in-type-1-diabetes-18259https://curecurrent.com/trials/improving-physical-activity-levels-in-the-arabic-speaking-residents-of-east-jerusalem-with-prediabetes-18260https://curecurrent.com/trials/stem-cell-educator-therapy-in-diabetes-18261https://curecurrent.com/trials/reversal-of-type-1-diabetes-in-children-by-stem-cell-educator-therapy-18262https://curecurrent.com/trials/neujia-anastomosis-for-treatment-of-obesity-and-type-ii-diabetes-18263https://curecurrent.com/trials/mbct-for-dm-distress-a-pilot-qusai-experimental-study-18264https://curecurrent.com/trials/comparison-of-the-use-of-energy-substrates-and-hormonal-regulation-of-blood-sugar-during-exercise-of-increasing-intensit-18265https://curecurrent.com/trials/formulas-for-diabetes-with-sucromalt-isomaltulose-on-glycemic-index-hormones-subjective-appetite-in-type-2-diabetes-18266https://curecurrent.com/trials/impact-of-pharmacist-in-cardiology-service-18267https://curecurrent.com/trials/a-12-month-randomized-efficacy-and-safety-study-of-0-5-mg-ranibizumab-vs-laser-in-chinese-diabetic-macular-edema-dme-pat-18268https://curecurrent.com/trials/diabeloop-wp7-crossover-evaluation-of-the-safety-and-the-efficacy-of-artificial-pancreas-diabeloop-wp7-18269https://curecurrent.com/trials/effects-of-wearable-technology-and-smart-phone-applications-based-exercise-training-in-patients-with-type-2-diabetes-18270https://curecurrent.com/trials/effect-of-metadoxine-on-oxidative-stress-in-non-alcoholic-hepatic-steatosis-18271https://curecurrent.com/trials/low-dose-colchicine-in-patients-with-type-2-diabetes-mellitus-and-microalbuminuria-18272https://curecurrent.com/trials/kinetics-of-ykl-40-protein-in-serum-of-cystic-fibrosis-patients-18273https://curecurrent.com/trials/dulaglutide-in-diabetic-patients-relationship-between-arterial-stiffness-endothelial-function-clinical-and-laboratory-va-18274https://curecurrent.com/trials/impact-of-a-nutritional-intervention-on-type1-diabetes-adult-with-metabolic-syndrome-18275https://curecurrent.com/trials/dietary-intake-eating-behavior-physical-activity-level-and-their-relationships-with-glycemic-and-weight-control-in-hong-18276https://curecurrent.com/trials/polarization-perception-in-health-and-disease-testing-a-new-sight-test-18277https://curecurrent.com/trials/home-based-proprioceptive-neuromuscular-facilitation-for-subjects-with-type-2-diabetes-mellitus-18278https://curecurrent.com/trials/registry-of-use-and-application-of-sensor-augmented-pump-sap-therapy-under-daily-life-conditions-18279https://curecurrent.com/trials/markers-of-vascular-calcification-in-diabetic-nephropathy-in-patients-with-diabetic-nephropathy-18280https://curecurrent.com/trials/effects-of-non-alcoholic-beer-in-patients-with-type-2-diabetes-18281https://curecurrent.com/trials/vildagliptin-in-older-adults-with-diabetes-and-mild-cognitive-impairment-18282https://curecurrent.com/trials/effect-of-low-glycemic-index-on-gestational-diabetes-mellitus-18283https://curecurrent.com/trials/characteristics-of-empagliflozin-initiators-18284https://curecurrent.com/trials/injectable-collagen-scaffold-combined-with-huc-mscs-for-the-improvement-of-erectile-function-in-men-with-diabetes-18285https://curecurrent.com/trials/cepppia-pilot-experimental-center-of-participative-and-individualized-predictive-prevention-in-auvergne-18286https://curecurrent.com/trials/fgf19-and-the-expression-of-irs-1-and-glut-1-in-gestational-diabetes-mellitus-18287https://curecurrent.com/trials/comparison-between-bioactive-silica-graft-plus-platelet-rich-fibrin-and-only-platelet-rich-fibrin-graft-in-intrabony-def-18288https://curecurrent.com/trials/effect-of-centella-asiatica-on-xerotic-skin-in-diabetes-mellitus-type-2-18289https://curecurrent.com/trials/role-of-liver-and-visceral-fat-in-glucose-and-lipid-metabolism-during-pregnancy-18290https://curecurrent.com/trials/an-observational-study-to-evaluate-cardiovascular-outcomes-of-t2dm-patientstreated-with-gemigliptin-18291https://curecurrent.com/trials/pioglitazone-special-drug-use-surveillance-metabolic-syndrome-in-patients-with-type-2-diabetes-mellitus-18292https://curecurrent.com/trials/trial-to-incentivise-adherence-for-diabetes-18293https://curecurrent.com/trials/vitamin-d-treatment-of-diabetic-patients-with-foot-ulcers-18294https://curecurrent.com/trials/creative-arts-diabetes-initiative-for-youth-young-adults-transitioning-to-adult-care-18295https://curecurrent.com/trials/seum-bile-acid-profile-in-type-2-diabetes-and-association-between-bile-cid-profile-and-adipokine-or-oxidative-stress-18296https://curecurrent.com/trials/altitude-exercise-and-glucose-metabolism-in-pre-diabetic-men-18297https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-biok-50b-on-glycemic-control-in-a-type-2-diabetes-population-18298https://curecurrent.com/trials/the-pk-and-pd-of-dapagliflozin-therapy-in-combination-with-insulin-in-japanese-subjects-with-t1dm-18299https://curecurrent.com/trials/hyaluronic-acid-with-scaling-root-planing-in-chronic-periodontitis-patients-with-diabetes-mellitus-type-2-18300https://curecurrent.com/trials/myocardial-regional-function-by-dobutamine-stress-echocardiography-in-the-metabolic-syndrome-and-type-2-diabetes-18301https://curecurrent.com/trials/assessment-of-the-efficacy-and-safety-of-a-new-medical-device-in-the-local-treatment-of-diabetic-foot-ulcers-18302https://curecurrent.com/trials/pre-start-intervention-trial-of-an-interactive-family-based-lifestyle-programme-18303https://curecurrent.com/trials/pioglitazone-tablets-specified-drug-use-survey-survey-on-glycemic-control-in-type-2-diabetic-patients-with-a-history-of-18304https://curecurrent.com/trials/insulin-management-for-exercise-in-patients-with-type-1-diabetes-18305https://curecurrent.com/trials/a-three-part-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-mk-2640-in-healthy-participants-part-18306https://curecurrent.com/trials/prevention-strategies-for-adolescents-at-risk-of-diabetes-18307https://curecurrent.com/trials/high-water-intake-in-polycystic-kidney-disease-18308https://curecurrent.com/trials/comparison-on-efficacy-and-safety-of-three-inpatient-insulin-therapy-in-type2-dm-18309https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-and-safety-initiation-and-titration-of-insulin-glargine-u300-in-insulin-na-ve-pati-18310https://curecurrent.com/trials/effect-of-diabetes-and-hepatic-enzymes-mutation-on-clopidogrel-vs-ticagrelor-activity-in-myocardial-infarction-mi-patien-18311https://curecurrent.com/trials/a-non-interventional-study-to-monitor-the-safety-and-effectiveness-of-trajenta-linagliptin-5-mg-q-d-in-korean-patients-w-18312https://curecurrent.com/trials/metagenomic-analysis-of-human-gut-microbiota-in-patients-with-metabolic-diseases-including-diabetes-18313https://curecurrent.com/trials/effect-of-epa-dha-supplement-life-style-modification-standard-treatment-on-clinical-outcome-lipid-membrane-composition-i-18314https://curecurrent.com/trials/prediction-of-fetal-macrosomia-by-us-18315https://curecurrent.com/trials/high-intensity-interval-training-in-prediabetes-18316https://curecurrent.com/trials/pharmaceutical-care-in-the-reduction-of-readmission-rates-in-diabetes-melitus-18317https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-semaglutide-once-weekly-in-monotherapy-or-in-combination-with-one-oad-in-ja-18318https://curecurrent.com/trials/long-term-safety-and-efficacy-of-empagliflozin-as-add-on-to-glp-1-ra-18319https://curecurrent.com/trials/effect-of-inulin-type-fructose-extracted-from-jerusalem-artichoke-on-improving-prediabetic-state-of-type-2-diabetes-18320https://curecurrent.com/trials/investigation-on-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-doses-of-a-long-acting-glp-1-anal-18321https://curecurrent.com/trials/study-of-efficacy-of-ranibizumab-in-different-regimens-in-patients-with-diabetic-macula-edema-18322https://curecurrent.com/trials/study-on-effects-of-testosterone-replacement-therapy-in-hypogonadal-type-2-diabetic-patients-seth2-18323https://curecurrent.com/trials/biaxial-microincision-cataract-surgery-technique-18324https://curecurrent.com/trials/protein-supplementation-body-composition-muscle-strength-and-postural-balance-18325https://curecurrent.com/trials/effect-of-dapagliflozin-on-the-progression-from-prediabetes-to-t2dm-in-subjects-with-myocardial-infarction-18326https://curecurrent.com/trials/shared-care-for-patients-with-type-2-diabetes-across-the-primary-and-secondary-health-care-sector-18327https://curecurrent.com/trials/continuous-glucose-monitoring-with-immediate-or-delayed-counseling-feedback-18328https://curecurrent.com/trials/a-two-part-trial-investigating-the-safety-of-nn9924-in-healthy-male-subjects-18329https://curecurrent.com/trials/phase-i-single-dose-escalation-clinical-trial-of-salvianolic-acid-a-tablets-18330https://curecurrent.com/trials/dietary-acid-load-during-pregnancy-and-gestational-diabetes-mellitus-18331https://curecurrent.com/trials/weight-loss-and-reversing-t2d-through-ehealth-coaching-18332https://curecurrent.com/trials/study-of-immune-response-in-obesity-and-type-2-diabetes-18333https://curecurrent.com/trials/comparison-of-factor-xii-levels-in-gestational-diabetic-and-healthy-pregnancies-18334https://curecurrent.com/trials/herbal-tea-in-the-treatment-of-type-2-diabetes-mellitus-18335https://curecurrent.com/trials/a-trial-evaluating-the-effects-of-a-one-year-lifestyle-intervention-in-obese-patients-with-type-2-diabetes-18336https://curecurrent.com/trials/chronic-periodontitis-microbiota-in-type-2-diabetes-mellitus-patients-18337https://curecurrent.com/trials/impact-of-whey-and-leucine-on-glycaemia-in-adults-without-diabetes-18338https://curecurrent.com/trials/effects-of-different-training-programs-in-chronic-disease-patients-18339https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-cs-3150-in-japanese-type-2-diabetic-subjects-with-microalbuminuria-18340https://curecurrent.com/trials/psychological-variables-and-hyperglycemia-in-diabetes-mellitus-18341https://curecurrent.com/trials/proteomic-prediction-and-renin-angiotensin-aldosterone-system-inhibition-prevention-of-early-diabetic-nephropathy-in-typ-18342https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-inflammatory-markers-18343https://curecurrent.com/trials/study-of-cs-3150-in-hypertensive-patients-with-type-2-diabetes-and-albuminuria-18344https://curecurrent.com/trials/evaluation-of-automated-insulin-pump-settings-using-the-advisor-pro-previously-called-md-logic-pump-advisor-three-segmen-18345https://curecurrent.com/trials/a-regulatory-requirement-non-interventional-study-to-monitor-safety-and-effectiveness-of-trajenta-duo-in-type-2-diabetes-18346https://curecurrent.com/trials/a-pan-asian-trial-comparing-efficacy-and-safety-of-nn5401-and-biphasic-insulin-aspart-30-in-type-2-diabetes-18347https://curecurrent.com/trials/five-year-mortality-rate-in-people-with-diabetic-foot-ulcer-18348https://curecurrent.com/trials/pharmacists-provide-telemedicine-in-addition-to-clinic-visits-to-improve-diabetes-management-18349https://curecurrent.com/trials/tianjin-gestational-diabetes-prevention-program-tgdpp-18350https://curecurrent.com/trials/comparison-of-nn5401-with-biphasic-insulin-aspart-30-in-type-2-diabetes-18351https://curecurrent.com/trials/study-of-the-effect-of-fragmin-in-the-treatment-of-neuroischaemic-foot-ulcers-in-diabetic-patients-18352https://curecurrent.com/trials/financial-incentives-for-low-socioeconomic-diabetic-patients-18353https://curecurrent.com/trials/reaching-better-health-study-a-website-to-improve-type-2-diabetes-self-management-18354https://curecurrent.com/trials/use-of-the-mydose-coach-digital-tool-for-self-titration-of-insulin-in-patients-with-type-2-diabetes-18355https://curecurrent.com/trials/the-effect-of-2-grams-daily-supplementation-of-sativa-nigra-oil-on-blood-glucose-levels-of-adults-18356https://curecurrent.com/trials/effect-of-dietary-oils-as-g-protein-coupled-receptor-agonists-on-glucose-tolerance-18357https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-of-anakinra-in-patients-with-rheumatoid-arthritis-and-diabetes-18358https://curecurrent.com/trials/ffar-agonist-on-incretins-insulin-lipids-and-inflammation-18359https://curecurrent.com/trials/dose-response-effect-of-pine-nut-oil-as-a-dual-ffa1-and-ffa4-agonist-on-glucose-tolerance-in-healthy-humans-18360https://curecurrent.com/trials/lifestyle-and-glucose-lowering-medication-in-t2dm-18361https://curecurrent.com/trials/behavioral-economics-in-provider-incentive-design-18362https://curecurrent.com/trials/exercise-meal-timing-and-postprandial-glucose-control-18363https://curecurrent.com/trials/investigating-the-postprandial-glucose-metabolism-after-treatment-with-faster-acting-insulin-aspart-in-subjects-with-typ-18364https://curecurrent.com/trials/influence-of-dairy-protein-breakfast-on-glycemia-weight-loss-and-clock-genes-in-t2d-18365https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-and-pharmacodynamic-properties-of-fiasp-in-geriatric-and-younger-adult-subject-18366https://curecurrent.com/trials/transplantation-of-microbes-for-treatment-of-metabolic-syndrome-nafld-18367https://curecurrent.com/trials/a-trial-investigating-the-pharmacodynamic-properties-of-nn1218-in-subjects-with-type-1-diabetes-18368https://curecurrent.com/trials/an-international-survey-on-hypoglycaemia-among-insulin-treated-patients-with-diabetes-18369https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-properties-of-fiasp-in-japanese-subjects-with-type-1-diabetes-18370https://curecurrent.com/trials/hyperglycemia-and-exercise-18371https://curecurrent.com/trials/non-interventional-study-on-safety-of-liraglutide-in-subjects-with-type-2-diabetes-18372https://curecurrent.com/trials/heparinized-islets-in-clinical-islet-transplantation-18373https://curecurrent.com/trials/the-effect-of-simvastatin-combined-with-ezetimibe-in-patients-with-stable-angina-and-diabetes-18374https://curecurrent.com/trials/medical-nutrition-therapy-program-and-eating-behavior-questionnaires-on-gestational-weight-gain-18375https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ertugliflozin-in-asian-participants-with-type-2-diabetes-and-inadequate-g-18376https://curecurrent.com/trials/umbrella-review-of-the-dash-dietary-pattern-and-cardiometabolic-risk-18377https://curecurrent.com/trials/school-based-program-on-metabolic-disease-18378https://curecurrent.com/trials/association-between-irisin-inflammatory-markers-and-metabolic-status-in-obese-children-with-type-2-diabetes-mellitus-18379https://curecurrent.com/trials/gip-glp-1-co-activity-in-subjects-with-obesity-lowering-of-food-intake-18380https://curecurrent.com/trials/gip-glp-1-co-activity-in-subjects-with-overweight-and-type-2-diabetes-lowering-of-food-intake-18381https://curecurrent.com/trials/obtain-a-good-blood-glucose-control-with-the-paradigm-real-time-system-18382https://curecurrent.com/trials/fit-for-delivery-a-study-of-the-effect-of-exercise-sessions-and-nutritional-counselling-on-pregnancy-outcome-18383https://curecurrent.com/trials/euglyca-application-in-children-and-adolescents-with-type-1-diabetes-mellitus-18384https://curecurrent.com/trials/use-of-ipro-2-in-real-life-diabetes-management-of-type-2-patients-in-india-18385https://curecurrent.com/trials/manchester-antenatal-vascular-service-18386https://curecurrent.com/trials/identify-bacteria-associated-with-metabolic-diseases-that-reside-both-in-intestinal-crypts-and-in-blood-18387https://curecurrent.com/trials/psychological-impact-in-diabetes-intervention-with-affect-school-and-basal-body-awareness-18388https://curecurrent.com/trials/blood-flow-change-after-free-flap-surgery-in-diabetic-patients-18389https://curecurrent.com/trials/efficacy-of-closed-loop-strategy-with-and-without-a-learning-component-in-children-and-adolescents-with-type-1-diabetes-18390https://curecurrent.com/trials/rifaximin-improves-gut-dysbiosis-in-insulin-resistance-and-type-2-diabetes-18391https://curecurrent.com/trials/comparison-of-laboratory-changes-food-intake-and-metabolic-profile-in-patients-with-obesity-and-type2-diabetes-mellitus-18392https://curecurrent.com/trials/carbohydrate-counting-and-dash-intervention-and-pregnancy-outcomes-among-women-with-gestational-diabetes-18393https://curecurrent.com/trials/effects-of-metformin-in-heart-failure-patients-18394https://curecurrent.com/trials/web-based-exercise-for-south-asian-people-with-type-2-diabetes-18395https://curecurrent.com/trials/obesity-and-type-2-diabetes-raising-the-issue-of-weight-management-in-primary-care-18396https://curecurrent.com/trials/combined-rg3-enriched-korean-red-ginseng-and-american-ginseng-in-the-management-of-hypertension-in-type-2-diabetes-18397https://curecurrent.com/trials/allopurinol-in-diabetes-mellitus-and-multivessel-coronary-artery-disease-18398https://curecurrent.com/trials/management-of-glycemia-following-a-pizza-meal-18399https://curecurrent.com/trials/effect-of-type-ii-diabetes-mellitus-with-neuropathy-on-the-clinical-use-of-rocuronium-18400https://curecurrent.com/trials/a-study-to-assess-the-addition-of-sitagliptin-to-metformin-compared-with-the-addition-of-dapagliflozin-to-metformin-in-p-18401https://curecurrent.com/trials/short-term-effects-of-perindopril-amlodipine-versus-perindopril-indapamide-in-type-2-diabetes-18402https://curecurrent.com/trials/effects-of-allium-hookeri-on-blood-glucose-18403https://curecurrent.com/trials/comparative-evaluation-of-1-2-atorvastatin-and-1-2-simvastatin-gel-local-drug-delivery-and-redelivery-in-chronic-periodo-18404https://curecurrent.com/trials/clinical-trial-to-evaluate-the-drug-drug-interaction-of-ckd-501-and-d308-18405https://curecurrent.com/trials/telemedicine-strategy-with-home-treatment-save-resources-18406https://curecurrent.com/trials/effects-of-acute-high-intensity-exercise-training-on-cardiac-function-in-type-ii-diabetes-18407https://curecurrent.com/trials/konjac-mannan-improves-glycemia-and-other-risk-factors-for-chd-in-t2dm-18408https://curecurrent.com/trials/taking-out-all-teeth-and-replacing-them-with-dentures-that-rest-on-implants-in-people-with-type-2-diabetes-18409https://curecurrent.com/trials/safety-of-wharton-jelly-in-erectile-dysfunction-18410https://curecurrent.com/trials/association-between-pseudoexfoliation-syndrome-and-diabetes-mellitus-18411https://curecurrent.com/trials/intensive-versus-conventional-glycemic-control-in-diabetic-foot-ulcer-healing-18412https://curecurrent.com/trials/oxldl-in-diabetes-mellitus-patients-and-disease-periodontal-18413https://curecurrent.com/trials/effects-of-berberine-hydrochloride-and-bifidobacterium-in-prediabetes-prevention-and-treatment-18414https://curecurrent.com/trials/efficacy-and-safety-of-basal-insulin-glargine-combination-with-exenatide-bid-vs-aspart30-in-t2dm-18415https://curecurrent.com/trials/comparison-of-exenatide-vs-biphasic-insulin-aspart-30-on-glucose-variability-in-type-2-diabetes-18416https://curecurrent.com/trials/effects-of-berberine-hydrochloride-and-bifidobacterium-in-diabetes-mellitus-prevention-and-treatment-18417https://curecurrent.com/trials/dcb-compared-stenting-in-popliteal-lesions-18418https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk-8655-in-participants-with-type-2-diabetes-mk-8655-002-18419https://curecurrent.com/trials/trial-of-switching-between-intravitreal-bevacizumab-avastin-intravitreal-dexamethasone-ozurdex-for-persistent-diabetic-m-18420https://curecurrent.com/trials/the-interaction-between-metformin-and-acute-exercise-18421https://curecurrent.com/trials/impact-of-pharmacotherapeutic-education-on-medication-adherence-and-adverse-outcomes-in-type-2-diabetes-18422https://curecurrent.com/trials/the-interaction-between-metformin-and-physical-training-18423https://curecurrent.com/trials/testing-different-messaging-approaches-to-increase-activation-of-a-healthyfood-benefit-in-adults-with-diabetes-18424https://curecurrent.com/trials/diabetes-care-management-compared-to-standard-diabetes-care-in-adolescents-and-young-adults-with-type-1-diabetes-18425https://curecurrent.com/trials/optimization-of-hepatic-hemodynamics-during-liver-surgery-18426https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-a-program-of-emotional-intelligence-in-adolescents-with-type-1-diabetes-intedi-18427https://curecurrent.com/trials/study-to-evaluate-mk-6096-in-the-treatment-of-painful-diabetic-neuropathy-pdn-in-adults-mk-6096-021-18428https://curecurrent.com/trials/impact-of-bedtime-snacks-on-glucose-control-in-type-2-diabetes-18429https://curecurrent.com/trials/diabetes-screening-risk-management-and-disease-management-in-a-high-risk-mental-health-population-part-ii-18430https://curecurrent.com/trials/evaluation-of-diagnostic-methods-and-dietary-treatment-of-diabetic-gastroparesis-18431https://curecurrent.com/trials/diabetes-screening-risk-management-and-disease-management-in-a-high-risk-mental-health-population-18432https://curecurrent.com/trials/response-of-inflammatory-markers-to-circuit-weight-training-in-diabetic-patients-18433https://curecurrent.com/trials/a-study-to-assess-cardiovascular-outcomes-following-treatment-with-omarigliptin-mk-3102-in-participants-with-type-2-diab-18434https://curecurrent.com/trials/autonomic-nervous-system-and-exercise-in-gestational-diabetes-18435https://curecurrent.com/trials/effect-of-structured-nutrition-education-in-type-1-diabetes-18436https://curecurrent.com/trials/a-study-of-autologous-induced-islet-body-with-type-1-diabetes-18437https://curecurrent.com/trials/the-effectiveness-of-multimedia-education-for-patients-with-type-2-diabe-mellitus-18438https://curecurrent.com/trials/the-effect-of-e-health-management-on-gestational-diabetes-control-18439https://curecurrent.com/trials/a-study-to-identify-biomarkers-of-hypoglycaemia-in-patients-with-type-2-diabetes-18440https://curecurrent.com/trials/liraglutide-or-insulin-in-real-life-usage-in-patients-with-diabetes-mellitus-type-2-18441https://curecurrent.com/trials/effect-of-yakult-ingestion-on-diet-induced-insulin-resistance-in-humans-18442https://curecurrent.com/trials/effects-of-replacing-diet-beverages-with-water-on-weight-maintenance-of-type-2-diabetic-obese-women-18-months-follow-up-18443https://curecurrent.com/trials/environmental-effects-type-1-diabetes-mellitus-18444https://curecurrent.com/trials/atrial-fibrillation-lifestyle-project-18445https://curecurrent.com/trials/study-of-ly2409021-in-participants-with-type-1-diabetes-18446https://curecurrent.com/trials/gaba-treatment-in-subjects-with-type-1-diabetes-18447https://curecurrent.com/trials/cho-loading-before-and-high-intermittent-cho-intake-during-physical-exercise-in-t1d-18448https://curecurrent.com/trials/resistant-starch-gut-bacteria-and-diabetes-18449https://curecurrent.com/trials/spices-inhibit-the-formation-and-absorption-of-malondialdehyde-from-hamburger-meat-18450https://curecurrent.com/trials/diet-obesity-and-genes-diogenes-18451https://curecurrent.com/trials/the-effectiveness-of-smart-health-management-program-for-patients-with-chronic-illness-18452https://curecurrent.com/trials/trimetazidine-in-myocardial-injury-after-percutaneous-coronary-intervention-in-patients-with-angina-and-diabetes-18453https://curecurrent.com/trials/finnish-vitamin-d-trial-find-18454https://curecurrent.com/trials/autologous-platelets-rich-plasma-aprp-treatment-vs-saline-dressing-for-the-management-of-diabetic-foot-ulcer-18455https://curecurrent.com/trials/cardiac-function-and-microcirculation-type-2-diabetes-and-echocardiographic-changes-over-time-18456https://curecurrent.com/trials/empagliflozin-based-quadruple-combination-vs-insulin-glarine-based-combination-therapy-in-patients-with-type-2-diabetes-18457https://curecurrent.com/trials/a-single-dose-study-of-ly2605541-in-participants-with-liver-impairment-18458https://curecurrent.com/trials/closed-loop-insulin-delivery-in-the-general-ward-18459https://curecurrent.com/trials/diagnostic-approaches-in-gestational-diabetes-and-impact-of-ethnicity-18460https://curecurrent.com/trials/a-trial-to-evaluate-the-effectiveness-of-the-pure-prairie-living-program-18461https://curecurrent.com/trials/observational-study-of-drug-naive-diabetes-receiving-insulin-therapy-18462https://curecurrent.com/trials/plasma-dihydroceramides-are-associated-with-hepatic-steatosis-in-type-1-and-type-2-diabetes-18463https://curecurrent.com/trials/study-of-carrageenan-s-effect-on-insulin-resistance-in-humans-18464https://curecurrent.com/trials/a-safety-and-tolerability-study-of-vc-02-combination-product-in-subjects-with-type-1-diabetes-mellitus-18465https://curecurrent.com/trials/effects-of-victoza-versus-lyxumia-on-gastroesophageal-reflux-gastric-emptying-and-gastric-acid-secretion-18466https://curecurrent.com/trials/the-arterial-measurement-of-the-blood-flow-volume-after-iloprost-stimulation-18467https://curecurrent.com/trials/preoperative-injection-of-bevacizumab-prior-to-vitreoretinal-surgery-in-diabetic-tractional-retinal-detachment-18468https://curecurrent.com/trials/diameter-changes-of-retinal-vessels-during-hypoxia-18469https://curecurrent.com/trials/dcb-dm101-in-healthy-volunteers-and-for-type-2-diabetes-mellitus-patients-18470https://curecurrent.com/trials/autoimmune-diabetes-accelerator-prevention-trial-18471https://curecurrent.com/trials/effects-of-olive-oil-and-bran-oil-on-antioxidant-levels-glycemic-control-and-lipid-profile-in-patient-type-2-dm-18472https://curecurrent.com/trials/acute-coronary-syndrome-in-diabetic-patients-18473https://curecurrent.com/trials/study-evaluating-novel-biomarkers-of-aki-acute-kidney-injury-in-post-operative-patients-18474https://curecurrent.com/trials/performance-characteristics-and-safety-assessment-of-a-non-invasive-glucose-monitoring-device-18475https://curecurrent.com/trials/hyperglucagonaemia-in-patients-with-type-2-diabetes-role-of-glucagon-clearance-18476https://curecurrent.com/trials/effect-of-co-administration-of-metformin-and-daclatasvir-on-the-pharmacokinetis-and-pharmacodynamics-of-metformin-18477https://curecurrent.com/trials/a-real-world-experience-of-dapagliflozin-in-type-2-diabetes-18478https://curecurrent.com/trials/role-of-glycaemic-index-and-high-protein-meal-in-response-of-blood-biomarkers-for-pre-diabetes-18479https://curecurrent.com/trials/treatment-of-type-2-diabetes-with-long-acting-basal-insulin-in-jordan-18480https://curecurrent.com/trials/aspirin-resistance-and-sleep-apnea-in-type-2-diabetic-patients-18481https://curecurrent.com/trials/emotional-disorders-and-outcomes-in-adults-with-type-2-diabetes-mellitus-at-primary-care-18482https://curecurrent.com/trials/effectiveness-of-a-mobile-technology-intervention-for-the-treatment-of-depression-18483https://curecurrent.com/trials/diabetic-retinopathy-screening-in-private-practice-18484https://curecurrent.com/trials/brown-adipose-tissue-in-type-1-diabetes-18485https://curecurrent.com/trials/evaluation-of-the-impact-of-a-nutritional-supplement-made-of-vegetable-oils-in-people-at-risk-of-diabetes-18486https://curecurrent.com/trials/intermittent-fasting-for-metabolic-health-does-meal-timing-matter-18487https://curecurrent.com/trials/changes-in-arterial-stiffness-and-endothelial-glycocalyx-in-patients-with-poorly-controlled-diabetes-mellitus-type-1-or-18488https://curecurrent.com/trials/phase-ii-study-to-evaluate-the-efficacy-and-safety-of-glassia-in-type-1-diabetes-18489https://curecurrent.com/trials/clinical-trial-using-the-proteolytic-fraction-p1g10-from-v-cundinamarcensis-to-heal-diabetic-foot-ulcer-18490https://curecurrent.com/trials/preoperative-oral-carbohydrate-treatment-minimizes-insulin-resistance-18491https://curecurrent.com/trials/simple-mobile-based-artificial-intelligence-algorithms-in-the-detection-of-diabetic-retinopathy-smart-study-18492https://curecurrent.com/trials/effect-of-vitamin-d-intake-in-pregnancy-to-prevent-recurrence-of-gestational-diabetes-18493https://curecurrent.com/trials/trial-for-tobacco-cessation-with-intensive-advice-in-diabetic-patients-the-itadi-project-18494https://curecurrent.com/trials/anais-a-spanish-version-of-the-dafne-programme-18495https://curecurrent.com/trials/the-development-of-contextual-cognitive-behavioural-approach-to-pdn-18496https://curecurrent.com/trials/functional-magnetic-resonance-imaging-of-brain-activity-in-patients-with-painful-diabetic-neuropathy-18497https://curecurrent.com/trials/a-study-to-compare-two-forms-of-ly2608204-in-healthy-people-18498https://curecurrent.com/trials/glycemic-control-and-treatment-satisfaction-in-children-with-type-1-diabetes-using-insulin-pumps-18499https://curecurrent.com/trials/ischemic-preconditioning-and-type-2-diabetes-18500https://curecurrent.com/trials/relationship-of-periodontal-disease-treatment-and-type-2-diabetes-mellitus-in-the-gullah-population-18501https://curecurrent.com/trials/do-taxes-reduce-the-purchasing-of-soda-18502https://curecurrent.com/trials/complement-inhibitor-eculizumab-in-clinical-islet-transplantation-18503https://curecurrent.com/trials/first-trimester-glycosylated-haemoglobin-und-plasma-glucose-in-women-at-high-risk-for-gestational-diabetes-18504https://curecurrent.com/trials/effect-of-managing-problematic-eating-behaviours-with-dietary-management-on-chronic-disease-self-management-18505https://curecurrent.com/trials/clinical-trial-of-yh14755-in-subjects-with-dyslipidemia-and-type-ii-diabetes-18506https://curecurrent.com/trials/the-effectiveness-of-low-carbohydrate-diet-in-reducing-polypharmacy-for-patients-with-type-2-diabetes-mellitus-18507https://curecurrent.com/trials/efficiency-and-cost-effectiveness-of-a-culturally-adopted-lifestyle-intervention-program-the-medim-study-18508https://curecurrent.com/trials/effectiveness-and-cost-effectiveness-of-the-check-your-health-preventive-programme-18509https://curecurrent.com/trials/trazodone-in-painful-diabetic-neuropathy-18510https://curecurrent.com/trials/glucose-variability-in-patients-with-type-1-diabetes-with-a-sucrose-added-diet-18511https://curecurrent.com/trials/nutrition-oral-health-and-type-2-diabetes-18512https://curecurrent.com/trials/spatio-temporal-gait-parameters-and-gait-symmetry-in-diabetic-lower-extremity-burn-injury-18513https://curecurrent.com/trials/empagliflozin-reduces-progression-of-diabetic-retinopathy-in-patients-with-high-risk-of-diabetic-macular-edema-18514https://curecurrent.com/trials/correlation-between-idiopathic-parkinson-s-disease-and-diabetes-mellitus-18515https://curecurrent.com/trials/the-effect-of-liraglutide-on-bone-turnover-bone-mass-and-bone-cell-function-18516https://curecurrent.com/trials/diet-diabetes-and-periodontitis-18517https://curecurrent.com/trials/type-2-diabetes-in-fayoum-18518https://curecurrent.com/trials/cerebral-tissue-oxygen-balance-affected-by-diabetes-mellitus-18519https://curecurrent.com/trials/i-care-stimulating-self-management-in-patients-with-type-2-diabetes-18520https://curecurrent.com/trials/azithromycin-insulin-diet-intervention-trial-in-type-1-diabetes-18521https://curecurrent.com/trials/prioritized-clinical-decision-support-cds-to-reduce-cardiovascular-risk-18522https://curecurrent.com/trials/creative-writing-for-type-2-diabetes-management-18523https://curecurrent.com/trials/nutritional-supplement-on-wound-healing-in-diabetic-foot-18524https://curecurrent.com/trials/the-vigorous-physical-activity-for-glycaemic-control-in-type-1-diabetes-vigor-trial-18525https://curecurrent.com/trials/telemedicine-as-a-means-to-achieving-good-diabetes-control-among-patients-with-type-2-diabetes-18526https://curecurrent.com/trials/efficacy-and-safety-of-nutraceuticals-in-patients-with-diabetes-mellitus-type-ii-and-dyslipidemia-18527https://curecurrent.com/trials/canola-mediterranean-diet-study-in-t2dm-18528https://curecurrent.com/trials/the-effect-of-vildagliptin-based-treatment-versus-sulfonylurea-on-glycemic-variability-oxidative-stress-glp-1-and-endoth-18529https://curecurrent.com/trials/a-phase-1-study-of-ertugliflozin-in-healthy-male-participants-mk-8835-020-18530https://curecurrent.com/trials/high-sensitive-crp-in-prediabetics-and-diabetes-18531https://curecurrent.com/trials/diabetes-training-program-for-health-professionals-from-hermosillo-sonora-18532https://curecurrent.com/trials/rotation-for-optimal-targeting-of-albuminuria-and-treatment-evaluation-rotate-2-18533https://curecurrent.com/trials/renal-resisitive-index-as-an-indicator-of-the-progression-of-diabetic-nephropathy-18534https://curecurrent.com/trials/pattern-laser-versus-conventional-laser-in-diabetic-retinopathy-18535https://curecurrent.com/trials/study-of-safety-and-efficacy-of-ertugliflozin-pf-04971729-mk-8835-in-participants-with-type-2-diabetes-and-hypertension-18536https://curecurrent.com/trials/ultrasound-classification-and-grading-of-lipohypertrophy-and-its-impact-on-glucose-variability-in-type-1-diabetes-18537https://curecurrent.com/trials/effect-of-pravastatin-in-the-subjects-with-prediabetes-or-early-diabetes-18538https://curecurrent.com/trials/safety-and-efficacy-of-ertugliflozin-in-the-treatment-of-participants-with-type-2-diabetes-mellitus-who-have-inadequate-18539https://curecurrent.com/trials/study-of-safety-and-efficacy-of-ertugliflozin-pf-04971729-mk-8835-in-participants-with-type-2-diabetes-mk-8835-016-18540https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-semaglutide-once-weekly-versus-sitagliptin-once-daily-in-japanese-subjects-18541https://curecurrent.com/trials/determinants-of-cognitive-impairment-among-geriatrics-18542https://curecurrent.com/trials/efficacy-and-safety-of-ertugliflozin-mk-8835-pf-04971729-with-sitagliptin-in-the-treatment-of-participants-with-type-2-d-18543https://curecurrent.com/trials/rural-andhra-pradesh-cardiovascular-prevention-study-rapcaps-18544https://curecurrent.com/trials/0-075-capsaicin-lotion-for-the-treatment-of-painful-diabetic-neuropathy-18545https://curecurrent.com/trials/ertugliflozin-and-sitagliptin-co-administration-factorial-study-vertis-factoral-mk-8835-005-18546https://curecurrent.com/trials/efficacy-of-pioglitazone-in-participants-with-inadequately-controlled-type-2-diabetes-mellitus-treated-with-stable-tripl-18547https://curecurrent.com/trials/the-relation-between-vitamin-d-and-gestational-diabetes-mellitus-18548https://curecurrent.com/trials/internet-intervention-for-diabetes-distress-18549https://curecurrent.com/trials/trial-of-an-internet-based-platform-for-managing-chronic-diseases-at-a-distance-18550https://curecurrent.com/trials/prevalence-of-hepatomegaly-in-children-and-adolescents-with-type-1-diabetes-mellitus-18551https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-kbp-042-in-patients-with-type-2-diabetes-18552https://curecurrent.com/trials/icbt-for-long-term-conditions-in-iapt-18553https://curecurrent.com/trials/comparing-efficacy-and-safety-of-insulin-degludec-insulin-aspart-twice-daily-and-biphasic-insulin-aspart-twice-daily-in-18554https://curecurrent.com/trials/shanghai-cohort-study-of-diabetic-eye-disease-18555https://curecurrent.com/trials/effect-of-dapagliflozin-on-vascular-functions-in-patients-with-type-2-diabetes-compared-to-gliclazide-18556https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-the-addition-of-omarigliptin-mk-3102-to-participants-with-ty-18557https://curecurrent.com/trials/a-preliminary-study-of-the-efficacy-and-safety-of-mk-8521-for-type-2-diabetes-mk-8521-004-18558https://curecurrent.com/trials/metformin-treatment-renal-function-and-lactic-acidosis-18559https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-omarigliptin-mk-3102-in-18-and-45-year-old-participants-with-type-2-diabetes-melli-18560https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ertugliflozin-in-participants-with-type-2-diabetes-mellitus-with-stage-3-chronic-k-18561https://curecurrent.com/trials/a-pharmacokinetic-study-of-mk-3102-in-participants-with-impaired-hepatic-function-mk-3102-031-18562https://curecurrent.com/trials/effect-of-sch-497079-on-metabolic-parameters-and-influence-of-race-ethnic-origin-on-therapeutic-response-study-p05338-co-18563https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ertugliflozin-in-participants-with-type-2-diabetes-mellitus-and-inadequat-18564https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-omarigliptin-mk-3102-compared-with-glimepiride-in-participants-with-type-18565https://curecurrent.com/trials/safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-mk-8666-in-participants-with-type-2-diabetes-mellitus-mk-86-18566https://curecurrent.com/trials/effects-of-dapagliflozin-treatment-on-urinary-proteomic-patterns-in-patients-with-type-2-diabetes-18567https://curecurrent.com/trials/evaluation-of-omarigliptin-mk-3102-in-obese-participants-and-in-participants-with-type-2-diabetes-mk-3102-004-18568https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-the-addition-of-omarigliptin-mk-3102-compared-with-the-addition-of-sitaglip-18569https://curecurrent.com/trials/omarigliptin-mk-3102-clinical-trial-add-on-to-oral-antihyperglycemic-agent-study-in-japanese-participants-with-type-2-di-18570https://curecurrent.com/trials/a-dose-range-finding-study-in-participants-with-type-2-diabetes-mk-3102-006-18571https://curecurrent.com/trials/live-your-life-without-diabetes-18572https://curecurrent.com/trials/variation-in-serum-levels-of-metformin-in-patients-with-reduced-renal-function-18573https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-mk-3577-in-participants-with-type-2-diabetes-mellitus-mk-3577-009-18574https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-omarigliptin-mk-3102-in-participants-with-type-2-diabetes-mellitus-t2dm-and-18575https://curecurrent.com/trials/microalbuminuria-and-allopurinol-in-type-1-diabetes-18576https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-mk-8245-in-participants-with-type-2-diabetes-mk-8245-012-18577https://curecurrent.com/trials/addition-of-omarigliptin-mk-3102-to-participants-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control-on-c-18578https://curecurrent.com/trials/a-study-of-omarigliptin-mk-3102-in-participants-with-impaired-renal-function-mk-3102-009-18579https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-omarigliptin-mk-3102-compared-with-glimepiride-in-participants-with-type-2-diabete-18580https://curecurrent.com/trials/performance-of-continuous-glucose-monitoring-systems-at-altitude-18581https://curecurrent.com/trials/translation-cultural-adaptation-and-validation-of-the-creole-versions-of-the-eq-5d-and-the-sf-36-questionnaires-in-patie-18582https://curecurrent.com/trials/feasibility-study-and-preliminary-application-study-on-iris-octa-18583https://curecurrent.com/trials/exercise-dose-response-for-diabetes-in-the-elderly-18584https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-trial-with-amg-108-in-patients-with-type-2-diabetes-mellitus-18585https://curecurrent.com/trials/physical-activity-monitoring-paediatric-type-1-diabetes-18586https://curecurrent.com/trials/linagliptin-as-add-on-therapy-to-empagliflozin-10-mg-or-25-mg-with-japanese-patients-with-type-2-diabetes-mellitus-18587https://curecurrent.com/trials/the-safety-and-efficacy-of-mk-1293-versus-lantus-in-participants-with-type-2-diabetes-mellitus-mk-1293-006-18588https://curecurrent.com/trials/pancreatic-exocrine-insufficiency-and-pancreatic-enzyme-supplementation-in-critically-ill-adult-patients-18589https://curecurrent.com/trials/the-exploration-of-optimal-treatment-scheme-in-patients-with-type-2-diabetes-inadequately-controlled-with-glargine-18590https://curecurrent.com/trials/an-intervention-to-examine-the-effect-of-vitamin-d-on-urine-protein-levels-in-type-2-diabetes-18591https://curecurrent.com/trials/effect-of-triticale-mung-bean-and-adzuki-bean-intervention-on-patients-with-type-2-diabetes-18592https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk-1293-compared-with-a-basal-insul-18593https://curecurrent.com/trials/celiac-disease-and-diabetes-dietary-intervention-and-evaluation-trial-18594https://curecurrent.com/trials/relationship-between-gestational-diabetes-mellitus-and-inflammatory-adipocytokins-in-obese-mothers-and-their-newborn-at-18595https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-glucose-lowering-efficacy-of-mk-0893-in-participants-with-type-2-diabetes-18596https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-mk-1293-compared-to-lantus-in-participants-with-type-1-diabetes-mellitus-t1dm-mk-1-18597https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-liraglutide-1-8-mg-day-to-liraglutide-0-9-mg-day-in-japanese-subjects-with-18598https://curecurrent.com/trials/first-research-study-to-compare-a-possible-new-medicine-nnc9204-1513-to-the-medicine-glucagon-in-healthy-people-18599https://curecurrent.com/trials/medication-regimen-complexity-and-glycemic-control-in-patients-with-diabetes-18600https://curecurrent.com/trials/ipragliflozin-add-on-long-term-study-in-japanese-participants-with-type-2-diabetes-mellitus-on-sitagliptin-mk-0431j-849-18601https://curecurrent.com/trials/study-of-gw823093-in-japanese-subjects-with-type-2-diabetes-mellitus-18602https://curecurrent.com/trials/corneal-confocal-microscopy-in-patients-with-type-1-diabetes-18603https://curecurrent.com/trials/double-blind-ipragliflozin-add-on-study-in-japanese-participants-with-type-2-diabetes-mellitus-who-have-inadequate-glyce-18604https://curecurrent.com/trials/diabetes-in-minor-stroke-tia-glucose-tolerance-and-haemostasis-a-long-term-follow-up-study-and-intervention-with-yoga-18605https://curecurrent.com/trials/longitudinal-study-of-chronic-wounds-using-novel-wound-measurement-technologies-18606https://curecurrent.com/trials/fetal-interventricular-septum-thickness-and-maternal-gestational-diabetes-control-18607https://curecurrent.com/trials/gw823093c-for-the-treatment-of-type-2-diabetes-mellitus-18608https://curecurrent.com/trials/a-non-interventional-study-of-ability-and-willingness-to-pay-for-biasp-30-in-a-real-world-population-with-type-2-diabete-18609https://curecurrent.com/trials/shoulder-corticosteroid-injection-in-diabetic-patients-18610https://curecurrent.com/trials/comparison-of-retinal-oxygenation-and-retinal-vessel-diameters-in-healthy-subjects-and-patients-with-diabetic-retinopath-18611https://curecurrent.com/trials/double-blind-sitagliptin-add-on-study-in-japanese-participants-with-type-2-diabetes-mellitus-who-have-inadequate-glycemi-18612https://curecurrent.com/trials/effect-of-bariatric-surgery-on-blood-pressure-18613https://curecurrent.com/trials/ziv-aflibercept-in-ocular-disease-requiring-anti-vegf-injection-18614https://curecurrent.com/trials/dietetic-and-hygiene-measures-in-metabolic-neuropathies-the-neurodiet-study-18615https://curecurrent.com/trials/efficacy-and-safety-of-coronary-amphilimus-eluting-stent-in-diabetic-patients-18616https://curecurrent.com/trials/safety-and-tolerability-of-pbi-4050-and-its-effects-on-the-biomarkers-in-subjects-with-alstr-m-syndrome-18617https://curecurrent.com/trials/paediatric-use-of-the-abbott-sensor-based-glucose-monitoring-system-18618https://curecurrent.com/trials/safety-and-tolerability-of-gx-g6-in-healthy-male-subjects-18619https://curecurrent.com/trials/dapagliflozin-on-hyperlipidemia-and-insulin-resistance-in-type-2-diabetic-patients-daphnis-study-18620https://curecurrent.com/trials/prognostic-value-of-the-circadian-pattern-of-ambulatory-blood-pressure-for-multiple-risk-assessment-18621https://curecurrent.com/trials/calcium-protein-and-gut-hormones-18622https://curecurrent.com/trials/depression-and-diabetes-control-trial-18623https://curecurrent.com/trials/effects-of-red-grape-cells-rgc-powder-in-type-2-diabetics-18624https://curecurrent.com/trials/a-crossover-trial-of-chitosan-oligosaccharide-on-post-prandial-glucose-control-in-subjects-with-normal-ifg-and-igt-18625https://curecurrent.com/trials/calcium-protein-co-ingestion-and-gut-hormones-18626https://curecurrent.com/trials/propolis-as-adjuvant-in-the-healing-of-human-diabetic-foot-wounds-18627https://curecurrent.com/trials/calcium-and-gut-hormones-18628https://curecurrent.com/trials/long-term-effect-of-splenectomy-on-metabolism-18629https://curecurrent.com/trials/co-administration-of-cabergoline-and-gliclazide-improve-glycemic-parameters-and-lipid-profile-in-t2dm-patients-18630https://curecurrent.com/trials/ertapenem-sodium-mk-0826-versus-piperacillin-tazobactam-sodium-for-the-treatment-of-diabetic-foot-infections-in-chinese-18631https://curecurrent.com/trials/efficacy-of-metformin-in-achieving-glycaemia-goals-as-recommended-for-the-treatment-of-gestational-diabetes-in-non-obese-18632https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-sitagliptin-simvastatin-fixed-dose-combination-fdc-in-participants-with-18633https://curecurrent.com/trials/pharmacokinetics-and-safety-tolerability-after-oral-administration-of-ckd-387-and-d484-in-healthy-adults-18634https://curecurrent.com/trials/the-effects-of-jeju-steaming-onion-oniro-on-reducing-body-fat-of-overweight-or-obesity-subjects-18635https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-mk-0431d-a-fixed-dose-combination-of-sitagliptin-and-simvastatin-for-the-treatment-18636https://curecurrent.com/trials/a-study-of-ly3325656-in-healthy-participants-and-participants-with-type-2-diabetes-18637https://curecurrent.com/trials/development-of-diabetes-in-adults-with-cystic-fibrosis-cf-18638https://curecurrent.com/trials/a-personalized-intervention-to-manage-physiological-stress-and-improve-sleep-patterns-18639https://curecurrent.com/trials/preservation-of-residual-beta-cell-mass-and-prevention-of-celiac-disease-in-children-with-recent-onset-type-1-diabetes-18640https://curecurrent.com/trials/metformin-add-on-regimen-comparison-study-in-japanese-participants-with-type-2-diabetes-mellitus-mk-0431a-136-18641https://curecurrent.com/trials/the-effectiveness-of-gamification-diabetes-education-program-for-poorly-controlled-type-2-diabetic-patients-18642https://curecurrent.com/trials/pharmacological-activation-of-brown-adipose-tissue-metabolism-18643https://curecurrent.com/trials/efficacy-and-safety-of-sitagliptin-metformin-fixed-dose-combination-fdc-compared-to-glimepiride-in-participants-with-typ-18644https://curecurrent.com/trials/effect-of-implantable-contraception-on-type-2-dm-and-metabolic-syndrome-in-women-with-history-of-gestational-dm-18645https://curecurrent.com/trials/teneligliptin-on-the-progressive-left-ventricular-diastolic-dysfunction-with-type-2-diabetes-mellitus-study-18646https://curecurrent.com/trials/the-efficacy-and-safety-of-ckd-501-added-to-d150-plus-d759-therapy-in-patients-with-type-2-diabetes-18647https://curecurrent.com/trials/optimizing-patient-usability-experience-for-chronic-care-18648https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-glimepiride-gliclazide-repaglinide-or-acarbose-when-added-to-sitagliptin-metformin-18649https://curecurrent.com/trials/the-effects-of-empagliflozin-on-arterial-wall-characteristics-18650https://curecurrent.com/trials/evaluation-of-the-diabeo-system-in-poorly-controlled-dm1-or-dm2-patients-treated-with-a-basal-bolus-insulin-regimen-18651https://curecurrent.com/trials/efficacy-of-sitagliptin-and-glibenclamide-on-the-glucose-variability-in-japanese-participants-with-type-2-diabetes-melli-18652https://curecurrent.com/trials/adaptive-study-of-il-2-dose-frequency-on-regulatory-t-cells-in-type-1-diabetes-18653https://curecurrent.com/trials/tart-cherry-juice-and-chronic-disease-risk-18654https://curecurrent.com/trials/clinical-study-of-bivalirudin-for-percutaneous-coronary-intervention-pci-18655https://curecurrent.com/trials/beyondsilos-more-personalised-and-coordinated-care-and-improved-outcomes-for-elderly-patients-18656https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-ertugliflozin-mk-8835-pf-04971729-in-participants-with-hepatic-impairment-an-18657https://curecurrent.com/trials/comparison-of-two-titration-programs-of-adding-insulin-detemir-to-oads-in-poorly-controlled-type-2-diabetes-18658https://curecurrent.com/trials/study-of-sitagliptin-for-the-treatment-of-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-insulin-mk-0431-2-18659https://curecurrent.com/trials/a-study-in-china-evaluating-the-safety-and-efficacy-of-adding-sitagliptin-to-stable-therapy-with-sulfonylurea-with-or-wi-18660https://curecurrent.com/trials/comparison-of-premixed-insulin-with-basal-plus-insulin-in-type-2-diabetes-patients-18661https://curecurrent.com/trials/a-study-in-china-evaluating-the-safety-and-efficacy-of-adding-sitagliptin-to-stable-therapy-with-insulin-with-or-without-18662https://curecurrent.com/trials/clinical-evaluation-of-fenugreek-seed-extract-a-nutraceutical-in-patients-with-type-2-diabetes-18663https://curecurrent.com/trials/tart-cherry-juice-and-markers-of-inflammation-cvd-and-diabetes-18664https://curecurrent.com/trials/early-intermittent-intensive-insulin-therapy-as-an-effective-treatment-of-type-2-diabetes-reset-it-pilot-study-18665https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-efficacy-of-the-addition-of-sitagliptin-in-participants-with-type-2-diabetes-m-18666https://curecurrent.com/trials/effects-of-glimepiride-on-recovery-from-hypoglycemia-in-participants-with-type-2-diabetes-mellitus-mk-0000-253-18667https://curecurrent.com/trials/the-swedish-study-on-paleolithic-diet-for-type-2-diabetes-18668https://curecurrent.com/trials/dci-a-community-based-pre-cardiac-surgery-diabetes-care-project-18669https://curecurrent.com/trials/effects-of-empagliflozin-on-cardiac-structure-in-patients-with-type-2-diabetes-18670https://curecurrent.com/trials/effect-of-sglt2-inhibitor-on-blood-glucose-profile-in-type-2-diabetic-patients-using-basal-insulin-18671https://curecurrent.com/trials/berlin-brandenburg-pregnancy-cohort-18672https://curecurrent.com/trials/evogliptin-in-type-2-diabetes-mellitus-evolution-evogliptina-no-diabetes-mellitus-tipo-2-18673https://curecurrent.com/trials/troponin-i-and-t-and-adverse-outcomes-in-patients-with-and-without-diabetes-mellitus-after-coronary-intervention-18674https://curecurrent.com/trials/relationship-between-blood-glucose-variability-and-prognosis-in-critically-ill-patients-18675https://curecurrent.com/trials/olivamine-containing-products-in-the-management-of-patients-with-nonhealing-lower-extremity-ulcers-18676https://curecurrent.com/trials/investigating-the-influence-of-omeprazole-on-the-pharmacokinetics-of-oral-semaglutide-in-healthy-subjects-18677https://curecurrent.com/trials/a-trial-investigating-the-effect-of-semaglutide-on-hypoglycaemic-counterregulation-compared-to-placebo-in-subjects-with-18678https://curecurrent.com/trials/efficacy-and-safety-of-ckd-501-added-to-d150-plus-d745-25mg-therapy-in-patients-with-type-2-diabetes-18679https://curecurrent.com/trials/a-phase-2-dose-finding-study-of-tak-272-in-participants-with-type-2-diabetes-mellitus-and-microalbuminuria-18680https://curecurrent.com/trials/title-an-open-non-comparative-multi-centre-post-marketing-clinical-follow-up-pmcf-investigation-to-evaluate-performance-18681https://curecurrent.com/trials/association-between-phthalates-exposure-and-renal-function-impairment-in-type-2-diabetes-18682https://curecurrent.com/trials/a-multi-professional-team-intervention-on-physical-activity-referrals-in-primary-care-patients-with-cardiovascular-risk-18683https://curecurrent.com/trials/motivational-instant-messaging-and-e-diabetes-prevention-programme-for-high-risk-of-type-2-diabetes-18684https://curecurrent.com/trials/a-study-of-omarigliptin-mk-3102-in-participants-with-type-2-diabetes-mellitus-with-chronic-kidney-disease-or-kidney-fail-18685https://curecurrent.com/trials/the-role-of-insulin-resistance-in-patients-with-heart-failure-and-type-2-diabetes-18686https://curecurrent.com/trials/association-of-bsmi-polymorphisms-in-vitamin-d-receptor-gene-with-diabetic-kidney-disease-18687https://curecurrent.com/trials/the-effect-of-early-nutrition-intervention-on-the-incidence-of-high-risk-patients-with-gestational-diabetes-18688https://curecurrent.com/trials/study-to-evaluate-the-effect-of-gwp42003-on-liver-fat-levels-in-participants-with-fatty-liver-disease-18689https://curecurrent.com/trials/comparison-of-2-novofine-needles-on-the-reflux-of-insulin-18690https://curecurrent.com/trials/effect-of-probiotic-and-smectite-gel-on-nafld-18691https://curecurrent.com/trials/empowerment-motivation-and-medical-adherence-emma-18692https://curecurrent.com/trials/reduction-of-risk-for-contrast-induced-nephropathy-18693https://curecurrent.com/trials/quality-of-control-and-sleep-in-children-with-diabetes-using-new-technology-18694https://curecurrent.com/trials/evaluation-of-a-treatment-and-education-program-for-diabetic-patients-who-use-flash-glucose-monitoring-18695https://curecurrent.com/trials/dermalix-efficacy-on-diabetic-foot-ulcers-18696https://curecurrent.com/trials/motivational-interview-in-adolescents-with-poorly-controlled-type-1-diabetes-18697https://curecurrent.com/trials/physical-activity-for-a-long-and-healthy-life-18698https://curecurrent.com/trials/proof-of-concept-identification-of-patient-specific-parameters-for-bolus-calculators-for-type-1-diabetes-18699https://curecurrent.com/trials/one-touch-verioiq-us-clinical-outcomes-study-18700https://curecurrent.com/trials/adolescence-and-diabetes-can-an-automated-closed-loop-system-improve-control-18701https://curecurrent.com/trials/safety-and-effectiveness-of-sglt-2-inhibitors-in-patients-with-heart-failure-and-diabetes-18702https://curecurrent.com/trials/protective-effects-of-sitagliptin-on-cell-function-in-patients-with-adult-onset-latent-autoimmune-diabetes-lada-18703https://curecurrent.com/trials/continuous-glucose-monitoring-and-hypoglycemia-unawareness-in-type-1-diabetes-18704https://curecurrent.com/trials/metformin-in-co-morbid-diabetes-or-prediabetes-and-serious-mental-illness-18705https://curecurrent.com/trials/carbohydrate-counting-in-children-and-adolescents-with-type-1-diabetes-18706https://curecurrent.com/trials/diabetes-in-pregnancy-and-pregnancy-outcomes-18707https://curecurrent.com/trials/effects-of-a-dipeptidyl-peptidase-4-inhibitor-sitagliptininsulin-on-the-progression-of-coronary-atherosclerosis-in-patie-18708https://curecurrent.com/trials/prp-use-in-diabetic-patients-undergoing-cesarean-section-18709https://curecurrent.com/trials/st-vincent-s-screening-to-prevent-heart-failure-study-18710https://curecurrent.com/trials/preoperative-intravitreal-ranibizumab-for-persistent-diabetic-vitreous-haemorrhage-18711https://curecurrent.com/trials/novel-strategies-to-improve-cardiometabolic-status-and-adherence-to-exercise-regimens-in-patients-at-high-risk-for-cardi-18712https://curecurrent.com/trials/clinical-study-to-compare-the-pharmacokinetic-characteristics-and-safety-between-ckd-380-10mg-and-d308-10mg-18713https://curecurrent.com/trials/perineural-platelet-rich-plasma-for-diabetic-neuropathy-pain-18714https://curecurrent.com/trials/effect-of-aspirin-vs-omega-3-fatty-acid-after-scaling-and-root-planing-in-type-ii-diabetic-patients-with-chronic-periodo-18715https://curecurrent.com/trials/a-study-of-the-co-administration-of-sitagliptin-and-atorvastatin-in-inadequately-controlled-type-2-diabetes-mellitus-mk-18716https://curecurrent.com/trials/tzu-chi-health-study-diabetes-and-cardiometabolic-health-components-18717https://curecurrent.com/trials/interval-walking-intervention-for-pregnant-women-diagnosed-with-gestational-diabetes-mellitus-18718https://curecurrent.com/trials/dlbs1033-treatment-in-diabetic-with-peripheral-arterial-disease-18719https://curecurrent.com/trials/the-effect-of-esomeprazole-on-type-2-diabetes-18720https://curecurrent.com/trials/changes-in-the-retinal-and-carotid-microcirculation-after-restoring-normoglycemia-in-patients-with-type-2-diabetes-18721https://curecurrent.com/trials/myocardial-infarction-with-non-obstructive-coronary-arteries-in-turkish-population-18722https://curecurrent.com/trials/changes-of-diet-physical-activity-and-sleep-pattern-and-their-effects-on-glycemic-and-weight-control-in-hong-kong-chines-18723https://curecurrent.com/trials/phase-iv-clinical-trial-to-investigate-the-effect-on-blood-glucose-of-evogliptin-in-patients-with-type-2-diabetes-evergr-18724https://curecurrent.com/trials/efficacy-and-safety-of-saxagliptin-vs-glimepiride-in-chinese-t2dm-patients-controlled-inadequately-with-metformin-18725https://curecurrent.com/trials/vitamin-b-complex-and-diabetic-nephropathy-in-type-1-diabetes-18726https://curecurrent.com/trials/effect-of-metformin-as-add-on-therapy-on-glycemic-control-and-other-outcomes-in-type-1-diabetes-18727https://curecurrent.com/trials/effectiveness-of-a-nurse-led-integrative-health-and-wellness-programme-among-newly-diagnosed-type-2-diabetes-patients-18728https://curecurrent.com/trials/prevalence-of-nocturnal-hypoglycemia-in-children-on-a-type-1-diabetes-tid-insulin-regimen-using-a-continuous-glucose-mon-18729https://curecurrent.com/trials/association-between-insulin-resistance-and-beta-cell-function-with-hba1c-in-diabetics-18730https://curecurrent.com/trials/screening-for-glucose-metabolism-disorders-in-cardiac-rehabilitation-18731https://curecurrent.com/trials/effect-of-apple-cider-vinegar-in-type-2-diabetics-18732https://curecurrent.com/trials/a-longitudinal-survey-of-health-in-bolivia-18733https://curecurrent.com/trials/effects-of-dpp4-inhibitor-versus-sglt2-inhibitor-18734https://curecurrent.com/trials/sardine-enriched-diet-for-prevention-type-2-diabetes-18735https://curecurrent.com/trials/biomarkers-of-diabetic-retinopathy-progression-18736https://curecurrent.com/trials/the-use-of-cgms-to-detect-alterations-of-blood-glucose-in-thalassemic-patients-18737https://curecurrent.com/trials/the-effect-of-soluble-fiber-to-reduce-post-prandial-glycemic-excursion-in-adults-with-cystic-fibrosis-18738https://curecurrent.com/trials/effect-of-resistant-starch-on-insulin-sensitivity-and-beta-cell-function-in-subjects-with-prediabetes-18739https://curecurrent.com/trials/concurrent-training-in-type-2-diabetes-18740https://curecurrent.com/trials/evaluation-of-the-effect-of-pulsatile-cuts-stendo3-on-vascular-function-patients-with-diabetes-type-2-18741https://curecurrent.com/trials/shanghai-children-and-adolescent-diabetes-eye-study-18742https://curecurrent.com/trials/clinical-study-to-assess-the-safety-and-pharmacokinetics-of-srt2104-in-type-2-diabetic-human-subjects-18743https://curecurrent.com/trials/glycated-hemoglobin-targets-and-glycemic-control-in-indonesian-diabetic-patients-18744https://curecurrent.com/trials/effect-of-nf-b-dependent-proinflammation-on-osteogenic-differentiation-of-the-mesenchymal-stem-cells-in-type-2-diabetes-18745https://curecurrent.com/trials/early-anatomical-physiological-and-clinical-changes-in-diabetic-macular-edema-after-intravitreal-aflibercept-injection-18746https://curecurrent.com/trials/evaluation-of-diamel-combined-with-insulin-in-diabetic-foot-ulcer-18747https://curecurrent.com/trials/sports-participation-in-children-and-adolescents-with-type-1-diabetes-mellitus-18748https://curecurrent.com/trials/determining-the-appropriate-intensity-of-exercise-to-prevent-post-exercise-hypoglycemia-in-persons-living-with-t1d-18749https://curecurrent.com/trials/comparison-between-enlite-and-flash-glucose-monitoring-18750https://curecurrent.com/trials/a-single-arm-feasibility-study-of-glycoleap-an-on-line-lifestyle-modification-and-self-management-program-for-people-wit-18751https://curecurrent.com/trials/healthy-eating-and-active-living-for-diabetes-glycemic-index-18752https://curecurrent.com/trials/glucose-kinetics-after-wheat-and-rye-breads-18753https://curecurrent.com/trials/effect-of-physical-therapy-in-improving-the-health-of-patients-with-diabetic-peripheral-neuropathy-18754https://curecurrent.com/trials/use-of-low-cost-mhealth-intervention-to-enhance-outcomes-of-noncommunicable-diseases-care-in-rural-and-refugee-settings-18755https://curecurrent.com/trials/shanghai-diabetic-eye-study-in-diabetics-18756https://curecurrent.com/trials/combining-saxagliptin-and-acarbose-to-improve-postprandial-glycaemia-in-type-2-diabetes-18757https://curecurrent.com/trials/metformin-rosuvastatin-combination-therapy-with-in-patients-with-type-2-diabetes-and-dyslipidemia-18758https://curecurrent.com/trials/biomarkers-derived-from-adipose-tissue-useful-for-diagnosis-and-prognosis-of-cardiovascular-risk-cvr-in-obese-patient-18759https://curecurrent.com/trials/mother-and-infant-study-cohort-misc-18760https://curecurrent.com/trials/early-changes-in-pulmonary-function-and-vascular-endothelial-function-and-the-correlation-between-them-in-t2dm-patients-18761https://curecurrent.com/trials/the-hydration-to-optimize-metabolism-h2o-metabolism-pilot-study-18762https://curecurrent.com/trials/clinical-evaluation-and-generalized-application-of-qing-hua-bu-three-dynamic-sequential-therapy-of-diabetic-ulcer-18763https://curecurrent.com/trials/antenatal-development-evaluated-prospectively-18764https://curecurrent.com/trials/health-education-during-ramadan-fasting-in-type-1-diabetes-18765https://curecurrent.com/trials/impact-of-web-and-smartphone-based-physical-activity-program-on-physical-activity-level-12-months-after-a-balneotherapy-18766https://curecurrent.com/trials/adolescent-type-1-diabetes-cardio-renal-intervention-trial-18767https://curecurrent.com/trials/impact-of-sleep-apnea-on-diabetic-foot-wound-18768https://curecurrent.com/trials/detecting-the-influence-of-cataract-surgery-on-the-development-of-diabetic-retinopathy-in-patients-with-diabetes-mellitu-18769https://curecurrent.com/trials/shanghai-beixinjing-diabetic-eyes-study-18770https://curecurrent.com/trials/comparison-of-different-fluence-settings-for-yellow-subthreshold-laser-treatment-in-diabetic-macular-edema-18771https://curecurrent.com/trials/vascular-and-metabolic-changes-in-postmenopausal-diabetics-18772https://curecurrent.com/trials/regulation-of-hepatic-insulin-extraction-18773https://curecurrent.com/trials/impact-of-dha-oat-on-metabolic-health-in-gestational-diabetes-mellitus-18774https://curecurrent.com/trials/nanshan-elderly-cohort-study-18775https://curecurrent.com/trials/a-method-to-evaluate-glucose-dependent-insulin-secretion-in-healthy-males-mk-0431-179-18776https://curecurrent.com/trials/health-outcomes-of-patients-with-stable-chronic-disease-managed-with-a-healthcare-kiosk-18777https://curecurrent.com/trials/leucopatch-in-the-management-of-hard-to-heal-diabetic-foot-ulcers-18778https://curecurrent.com/trials/for-adipose-tissue-diabetes-variants-fatdiva-18779https://curecurrent.com/trials/predictability-of-preoperative-hemoglobin-a1c-in-diabetic-patients-underwent-off-pump-coronary-artery-bypass-surgery-a-r-18780https://curecurrent.com/trials/gemigliptin-dapagliflozin-empagliflozin-ddi-study-18781https://curecurrent.com/trials/retromaster-retrospective-cohort-mrc-abpi-stratification-and-extreme-response-mechanism-in-diabetes-18782https://curecurrent.com/trials/promaster-prospective-cohort-mrc-abpi-stratification-and-extreme-response-mechanism-in-diabetes-18783https://curecurrent.com/trials/mastermind-understanding-individual-variation-in-treatment-response-in-type-2-diabetes-18784https://curecurrent.com/trials/development-of-structured-exercise-program-for-t2dm-management-18785https://curecurrent.com/trials/maternal-serum-pentraxin-3-in-early-pregnancy-to-predict-gestational-diabetes-mellitus-18786https://curecurrent.com/trials/saxagliptin-in-combination-with-dapagliflozin-effects-on-islet-cell-function-18787https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-added-to-continuous-subcutaneous-insulin-infusion-in-uncontrolled-type-2-diabetes-18788https://curecurrent.com/trials/tai-chi-quan-improving-biochemistry-and-quality-of-life-in-type-2-diabetes-18789https://curecurrent.com/trials/autologous-bone-marrow-transplant-in-chronic-insulin-dependent-diabetic-patients-18790https://curecurrent.com/trials/neurocognitive-impact-of-hypoglycemia-in-type-1-diabetes-18791https://curecurrent.com/trials/multiple-ascending-dose-study-in-healthy-male-subjects-and-overweight-to-obese-male-and-female-type-2-diabetes-mellitus-18792https://curecurrent.com/trials/nursing-interventions-for-glycemic-control-18793https://curecurrent.com/trials/comparison-of-an-artificial-pancreas-versus-threshold-low-glucose-suspend-in-type-1-diabetic-children-18794https://curecurrent.com/trials/dm1-effects-of-carbo-counting-on-glycemic-control-18795https://curecurrent.com/trials/determination-of-maternal-and-neonatal-apelinemia-in-obese-women-during-pregnancy-18796https://curecurrent.com/trials/a-thorough-qtc-evaluation-of-the-effect-of-semaglutide-on-cardiac-repolarisation-in-healthy-subjects-18797https://curecurrent.com/trials/the-effect-of-mindfulness-based-stress-reduction-in-patients-with-painful-diabetic-peripheral-neuropathy-18798https://curecurrent.com/trials/umbrella-review-and-updated-systematic-review-and-meta-analysis-of-pulses-legumes-and-incident-cardiometabolic-diseases-18799https://curecurrent.com/trials/effects-of-dietary-fiber-on-glucose-control-in-subjects-with-type-2-diabetes-mellitus-18800https://curecurrent.com/trials/bauhinia-forficata-in-diabetic-patients-18801https://curecurrent.com/trials/prediabetes-and-non-obstructive-coronary-atherosclerosis-18802https://curecurrent.com/trials/fasted-exercise-in-people-with-type-1-diabetes-18803https://curecurrent.com/trials/comparison-of-rice-richen-and-wheaten-richen-meal-on-glucose-control-among-chinese-women-with-gestational-diabetes-melit-18804https://curecurrent.com/trials/the-clinical-study-to-assess-the-effect-of-the-amount-of-carbohydrate-intake-and-meals-differing-in-glycemic-index-gi-in-18805https://curecurrent.com/trials/autologous-micro-fragmented-adipose-tissue-in-the-treatment-of-minor-amputations-of-diabetic-foot-18806https://curecurrent.com/trials/evolution-of-interleukin-7-fat-mass-and-metabolic-profile-before-and-after-transplantation-18807https://curecurrent.com/trials/transplantation-of-autologous-stem-cells-for-the-treatment-of-type-1-diabetes-mellitus-18808https://curecurrent.com/trials/sensor-augmented-insulin-pump-therapy-in-new-onset-diabetes-after-transplantation-18809https://curecurrent.com/trials/the-artificial-pancreas-in-very-young-children-with-t1d-pilot-kidsap01-18810https://curecurrent.com/trials/hit-in-people-with-type-1-diabetes-18811https://curecurrent.com/trials/arterial-calcification-in-the-diabetes-18812https://curecurrent.com/trials/are-audiovisual-materials-superior-to-printed-materials-in-improving-awareness-among-type-2-diabetic-patients-18813https://curecurrent.com/trials/effects-of-structured-group-education-on-quality-of-life-and-glycemic-control-in-type-1-diabetes-18814https://curecurrent.com/trials/mineralocorticoid-receptor-antagonists-in-type-2-diabetes-18815https://curecurrent.com/trials/acute-whole-body-vibration-change-the-glycemic-and-lactate-levels-18816https://curecurrent.com/trials/applying-the-new-authority-model-in-the-treatment-of-poorly-controlled-diabetic-adolescents-and-their-families-18817https://curecurrent.com/trials/curcumin-on-nfe2l2-gene-expression-antioxidant-capacity-and-renal-function-according-to-rs35652124-in-diabetic-nephropat-18818https://curecurrent.com/trials/medico-economical-assessment-of-telemedicine-during-chronic-diabetes-related-foot-wound-management-18819https://curecurrent.com/trials/factors-associated-with-cesarean-delivery-in-women-with-type-1-diabetes-18820https://curecurrent.com/trials/does-time-restricted-feeding-improve-glycaemic-control-in-overweight-men-18821https://curecurrent.com/trials/insulin-in-total-parenteral-nutrition-18822https://curecurrent.com/trials/intervention-study-effectiveness-of-smartphone-delivered-interval-walking-training-to-patients-with-type-2-diabetes-18823https://curecurrent.com/trials/study-of-offspring-of-women-with-type-1-diabetes-18824https://curecurrent.com/trials/pioglitazone-protects-diabetes-mellitus-dm-patients-against-re-infarction-ppar-study-18825https://curecurrent.com/trials/pilot-study-to-evaluate-the-safety-and-efficacy-of-5-ala-sfc-in-type-ii-diabetes-18826https://curecurrent.com/trials/insulin-based-strategies-to-prevent-hypoglycemia-during-exercise-18827https://curecurrent.com/trials/community-health-worker-diabetes-prevention-intervention-18828https://curecurrent.com/trials/the-effect-of-combination-lumacaftor-and-ivacaftor-on-markers-of-hyperglycemia-18829https://curecurrent.com/trials/18f-sodium-fluoride-18f-naf-pet-ct-imaging-to-identify-vulnerable-plaques-in-patients-with-diabetes-18830https://curecurrent.com/trials/efficacy-study-of-liraglutide-vs-sitagliptin-vs-glargine-on-liver-fat-in-t2dm-subjects-18831https://curecurrent.com/trials/evaluation-system-and-clinical-application-for-diabetic-retinopathy-18832https://curecurrent.com/trials/evaluation-of-microcirculation-of-peripheral-vascular-disease-in-diabetes-18833https://curecurrent.com/trials/diabetes-virus-detection-project-intervention-with-gad-alum-18834https://curecurrent.com/trials/early-changes-of-diabetes-parameters-after-obesity-therapy-18835https://curecurrent.com/trials/glucotoxicity-and-acute-exercise-18836https://curecurrent.com/trials/this-research-hypothesizes-that-the-use-of-a-rigid-rocker-sole-reduces-the-recurrence-rate-of-diabetic-foot-ulcers-in-pa-18837https://curecurrent.com/trials/screening-with-fibrotouch-for-advanced-liver-fibrosis-in-nafld-patients-with-underlying-type-2-diabetes-18838https://curecurrent.com/trials/impact-of-rutin-and-vitamin-c-combination-on-oxidative-stress-insulin-sensitivity-and-lipid-profile-in-type-2-diabetic-p-18839https://curecurrent.com/trials/dietary-fiber-and-cardiovascular-inflammatory-markers-18840https://curecurrent.com/trials/the-cost-efficacy-of-psychological-intervention-for-strengthening-parental-authority-among-parents-of-diabetic-adolescen-18841https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-oral-semaglutide-in-subjects-with-hepatic-impairment-18842https://curecurrent.com/trials/non-invasive-breath-based-acetone-meter-easy-check-18843https://curecurrent.com/trials/effect-of-empagliflozin-on-macrovascular-and-microvascular-circulation-and-on-endothelium-function-18844https://curecurrent.com/trials/the-vitamin-b-status-in-type-2-diabetes-vita-study-18845https://curecurrent.com/trials/prospective-randomized-multicentre-open-label-phase-ii-iii-study-to-assess-efficacy-and-safety-of-ranibizumab-0-5-mg-int-18846https://curecurrent.com/trials/the-belgian-diabetes-in-pregnancy-study-bedip-n-study-18847https://curecurrent.com/trials/cardiovascular-health-and-text-messaging-diabetes-mellitus-chat-dm-study-18848https://curecurrent.com/trials/screening-diabetes-patients-for-nafld-with-controlled-attenuation-parameter-and-liver-stiffness-measurements-18849https://curecurrent.com/trials/cardiovascular-health-and-texting-messaging-chat-study-18850https://curecurrent.com/trials/influence-of-injection-technique-of-premixed-insulin-on-glucose-excursion-in-type-2-diabetes-mellitus-18851https://curecurrent.com/trials/effect-of-dapagliflozin-on-microvascular-and-macrovascular-circulation-and-total-body-sodium-content-18852https://curecurrent.com/trials/the-effect-of-cbt-based-weight-loss-program-on-obesity-18853https://curecurrent.com/trials/sex-hormone-binding-globulin-testosterone-and-glycemic-control-in-patients-with-type-2-diabetes-18854https://curecurrent.com/trials/oxfordshire-women-and-their-children-s-health-18855https://curecurrent.com/trials/gene-virus-interactions-implicated-in-type-1-diabetes-18856https://curecurrent.com/trials/b-vitamins-and-polyneuropathy-in-patients-with-type-2-diabetes-18857https://curecurrent.com/trials/small-steps-for-big-changes-a-lifestyle-program-to-reduce-the-risk-of-developing-type-2-diabetes-18858https://curecurrent.com/trials/the-influence-of-acute-hyperglycaemia-on-brain-in-t1d-18859https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-to-improve-emotional-wellbeing-and-glycaemic-control-in-diabetes-18860https://curecurrent.com/trials/trientine-hydrochloride-for-the-prevention-of-macular-edema-after-cataract-surgery-in-patients-with-type-2-diabetes-mell-18861https://curecurrent.com/trials/study-to-evaluate-the-effect-of-isis-gcgrrx-on-hepatic-lipid-and-glycogen-content-in-type-2-diabetes-18862https://curecurrent.com/trials/the-effect-of-acipimox-on-glp-glucagon-like-peptide-1-secretion-18863https://curecurrent.com/trials/the-effect-of-resistant-starch-bagels-on-risk-factors-of-type-2-diabetes-and-colorectal-cancer-18864https://curecurrent.com/trials/effect-of-different-exercises-on-musculoskeletal-pain-glucose-level-and-quality-of-life-among-patients-with-diabetes-18865https://curecurrent.com/trials/various-serving-sizes-of-lentils-on-blood-glucose-and-insulin-18866https://curecurrent.com/trials/yerba-mate-ilex-paraguariensis-a-st-hil-assessment-of-cardiovascular-health-18867https://curecurrent.com/trials/dd2-coronary-plaque-morphology-and-plaque-progression-18868https://curecurrent.com/trials/evaluation-and-validation-of-new-biomarkers-by-mass-spectrometry-18869https://curecurrent.com/trials/effects-of-sglt2-inhibitor-on-hemodynamic-parameters-in-resistant-hypertensive-subjects-18870https://curecurrent.com/trials/effect-of-administration-of-resveratrol-on-glycemic-variability-in-individuals-with-type-2-diabetes-mellitus-18871https://curecurrent.com/trials/glycemic-and-satiety-response-study-of-fibre-enriched-pudding-products-18872https://curecurrent.com/trials/effects-of-obex-in-overweight-and-obese-patients-18873https://curecurrent.com/trials/the-role-and-effectiveness-of-diabetes-coaches-in-british-columbia-18874https://curecurrent.com/trials/cardiovascular-health-study-chs-events-follow-up-study-18875https://curecurrent.com/trials/the-effect-of-the-walking-exercise-training-given-according-to-transtheoretical-model-and-follow-up-on-improving-exercis-18876https://curecurrent.com/trials/failure-rate-of-glyburide-and-metformin-among-gestational-diabetics-18877https://curecurrent.com/trials/using-mhealth-to-modernize-diabetes-care-18878https://curecurrent.com/trials/assessment-of-tissue-oxygenation-using-multispectral-imaging-18879https://curecurrent.com/trials/disruption-of-immune-homeostasis-in-type-2-diabetics-with-generalized-chronic-periodontitis-18880https://curecurrent.com/trials/investigating-ultrasound-debridement-in-wound-care-18881https://curecurrent.com/trials/is-it-possible-to-screen-for-type-2-diabetes-at-day-2-in-gestational-diabetes-mellitus-patients-postpartum-18882https://curecurrent.com/trials/gestational-diabetes-insulin-or-oral-hypoglycemic-agents-18883https://curecurrent.com/trials/early-screening-for-gestational-diabetes-mellitus-18884https://curecurrent.com/trials/left-internal-thoracic-artery-bypass-versus-percutaneous-revascularization-in-diabetics-18885https://curecurrent.com/trials/efficacy-study-of-diacerein-on-glycemic-control-and-liver-fat-in-type-2-diabetes-subjects-18886https://curecurrent.com/trials/variation-in-sulphonylurea-response-in-type-2-diabetes-18887https://curecurrent.com/trials/glycemic-objectives-of-women-with-gestational-diabetes-mellitus-18888https://curecurrent.com/trials/gestational-diabetes-mellitus-and-cardiometabolic-syndrome-in-offspring-18889https://curecurrent.com/trials/diagnosis-test-for-gestational-diabetes-mellitus-18890https://curecurrent.com/trials/tenelia-triple-combination-study-18891https://curecurrent.com/trials/hypoglycaemia-in-people-with-type-2-diabetes-in-primary-care-18892https://curecurrent.com/trials/the-production-of-reactive-oxygen-species-in-response-to-glutathione-supplementation-and-acute-exercise-18893https://curecurrent.com/trials/teneligliptin-glimepiride-ddi-study-18894https://curecurrent.com/trials/study-for-safety-and-effectiveness-of-rwj-333369-carsibamate-for-the-treatment-of-diabetic-peripheral-neuropathy-dpn-18895https://curecurrent.com/trials/a-diabetes-improvement-in-medical-therapy-versus-sadjb-study-18896https://curecurrent.com/trials/integrated-primary-care-for-diabetes-and-cardiovascular-disease-18897https://curecurrent.com/trials/comparison-of-the-efficacy-of-rapid-acting-aspart-and-faster-acting-aspart-within-the-context-of-single-hormone-closed-l-18898https://curecurrent.com/trials/mobile-exergaming-in-type-2-diabetes-18899https://curecurrent.com/trials/personalising-treatment-of-diabetic-nephropathy-18900https://curecurrent.com/trials/effectiveness-of-glucose-control-cell-function-in-response-to-short-term-insulin-pump-therapy-in-type-2-diabetes-18901https://curecurrent.com/trials/drug-eluting-stent-for-diabetic-patients-in-coronary-artery-disease-treatment-18902https://curecurrent.com/trials/the-impact-of-telehealthcare-intervention-on-glycemic-control-in-children-and-adolescents-with-type-1-diabetes-18903https://curecurrent.com/trials/body-composition-and-risk-for-development-of-pre-diabetes-in-post-menopausal-chinese-women-in-singapore-18904https://curecurrent.com/trials/predicting-response-to-incretin-based-agents-in-type-2-diabetes-18905https://curecurrent.com/trials/the-effect-of-lifestyle-intervention-versus-gastric-bypass-on-various-comorbidities-in-morbidly-obese-subjects-18906https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-oral-semaglutide-in-subjects-with-various-degrees-of-impaired-renal-function-18907https://curecurrent.com/trials/cct-for-older-diabetic-adults-18908https://curecurrent.com/trials/human-vasodilatory-effect-of-glp-1-18909https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-multiple-doses-of-oshadi-icp-oshadi-oral-insulin-in-patients-with-type-1-diabetes-me-18910https://curecurrent.com/trials/prevention-of-end-stage-kidney-disease-by-darbepoetin-alfa-in-chronic-kidney-disease-patients-with-nondiabetic-kidney-di-18911https://curecurrent.com/trials/continuous-glucose-monitoring-in-new-mothers-with-type-1-diabetes-18912https://curecurrent.com/trials/a-trial-to-assess-the-pharmacokinetics-pharmacodynamics-and-the-safety-and-tolerability-of-semaglutide-in-healthy-male-j-18913https://curecurrent.com/trials/a-comparison-of-computerised-versus-interviewer-administered-approach-for-assessing-health-related-quality-of-life-18914https://curecurrent.com/trials/investigation-for-clinical-efficacy-and-safety-of-ipragliflozin-50mg-and-100mg-on-type-ii-diabetes-18915https://curecurrent.com/trials/use-of-copeptin-in-diabetes-insipidus-18916https://curecurrent.com/trials/understanding-local-determinants-of-cardiovascular-disease-and-diabetes-18917https://curecurrent.com/trials/evaluation-of-diabetes-control-and-effect-on-transmission-and-development-of-tuberculosis-18918https://curecurrent.com/trials/effect-of-carnosine-on-diabetes-and-cardiovascular-risk-factors-18919https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-thr-317-for-the-treatment-of-diabetic-macular-oedema-dme-18920https://curecurrent.com/trials/cardiovascular-autonomic-neuropathy-in-patients-with-type-1-diabetes-mellitus-18921https://curecurrent.com/trials/long-term-effectiveness-of-liraglutide-for-treatment-of-type-2-diabetes-in-daily-practice-18922https://curecurrent.com/trials/quality-of-life-and-personality-traits-in-patients-with-type-1-diabetes-18923https://curecurrent.com/trials/riscaid-study-remote-ischemic-conditioning-for-angiopathy-in-diabetes-18924https://curecurrent.com/trials/to-evaluate-the-comparative-efficacy-of-lucentis-ranibizumab-0-5mg-intravitreal-injection-in-patients-with-diabetic-macu-18925https://curecurrent.com/trials/flexible-catheter-for-insulin-in-diabetes-18926https://curecurrent.com/trials/the-effects-of-metformin-on-glycemic-control-and-insulin-sensitivity-in-adolescents-with-t1dm-18927https://curecurrent.com/trials/the-effect-of-insoluble-yeast-beta-glucan-intake-on-pre-diabetic-patients-18928https://curecurrent.com/trials/exenatide-and-impaired-hypoglycaemic-awareness-in-type-1-diabetes-18929https://curecurrent.com/trials/evaluation-of-the-eareeg-system-for-detection-of-hypoglycaemia-induced-changes-in-the-eeg-in-subjects-with-type-1-diabet-18930https://curecurrent.com/trials/diabetes-research-on-patient-stratification-direct-glp-1r-agonists-18931https://curecurrent.com/trials/effect-of-polyherbal-compound-for-control-of-blood-sugar-in-impaired-glucose-tolerance-and-diabetes-18932https://curecurrent.com/trials/gos-and-insulin-sensitivity-18933https://curecurrent.com/trials/detecting-and-addressing-preclinical-disability-18934https://curecurrent.com/trials/acute-effects-of-moderate-versus-high-intensity-exercise-on-insulin-sensitivity-in-gestational-diabetes-mellitus-18935https://curecurrent.com/trials/study-of-combined-topical-growth-factor-and-protease-inhibitor-in-chronic-wound-healing-18936https://curecurrent.com/trials/pregnancy-remote-monitoring-of-women-at-risk-for-gestational-diabetes-18937https://curecurrent.com/trials/prospective-follow-up-of-a-cohort-of-pre-diabetics-in-the-north-of-france-diabenord-18938https://curecurrent.com/trials/dimini-diabetes-mellitus-not-me-18939https://curecurrent.com/trials/the-indorse-study-inhibition-of-dipeptidyl-peptidase-iv-outcomes-on-renal-sodium-excretion-18940https://curecurrent.com/trials/a-mobile-smartphone-application-to-promote-a-healthy-diet-and-physical-activity-among-pregnant-women-with-gdm-rct-18941https://curecurrent.com/trials/effects-of-physical-exercise-on-blood-glucose-and-pain-from-the-musculoskeletal-system-in-patients-with-type-2-diabetes-18942https://curecurrent.com/trials/basal-insulin-and-compensation-glycemic-in-diabetic-patients-in-basal-bolus-outpatient-18943https://curecurrent.com/trials/heat-shock-response-is-blunted-in-elderly-diabetic-people-but-recovered-by-strength-training-18944https://curecurrent.com/trials/mesenchymal-stem-cell-therapy-for-type-1-diabetes-mellitus-patients-18945https://curecurrent.com/trials/a-comparison-of-the-effect-of-warm-and-cold-water-exercise-training-on-vascular-function-in-type-2-diabetic-patients-18946https://curecurrent.com/trials/efficacy-of-coenzyme-q10-in-pediatrics-with-type-1-diabetes-mellitus-18947https://curecurrent.com/trials/postprandial-blood-glucose-and-insulin-levels-following-consumption-of-lentil-containing-food-products-18948https://curecurrent.com/trials/cardiovascular-health-and-risk-modification-in-family-health-teams-18949https://curecurrent.com/trials/empa-add-on-to-insulin-in-japanese-patient-with-type-1-diabetes-mellitus-18950https://curecurrent.com/trials/which-exercises-should-diabetic-patients-do-18951https://curecurrent.com/trials/compliance-with-the-european-society-of-cardiology-prevention-guidelines-in-patients-at-high-cardiovascular-disease-risk-18952https://curecurrent.com/trials/investigate-the-effect-of-food-on-the-pharmacokinetics-of-jlp-1310-in-healthy-male-volunteers-18953https://curecurrent.com/trials/evaluation-of-self-reported-walking-impairment-in-predominantly-illiterate-patients-18954https://curecurrent.com/trials/the-pk-characteristics-of-the-co-administration-of-metformin-sr-and-rosuvastatin-and-jlp-1310-in-healthy-male-volunteers-18955https://curecurrent.com/trials/the-pharmacokinetic-study-of-wh-1-ointment-in-subjects-with-chronic-diabetic-foot-ulcers-18956https://curecurrent.com/trials/clinical-trial-to-investigate-the-pharmacokinetics-drug-interaction-between-metformin-and-rosuvastatin-18957https://curecurrent.com/trials/evaluating-the-effect-of-a-diabetes-health-coach-in-individuals-with-type-2-diabetes-18958https://curecurrent.com/trials/cardioprotective-and-metabolic-effects-of-metformin-in-patients-with-heart-failure-and-diabetes-18959https://curecurrent.com/trials/an-observational-study-to-describe-the-effectiveness-of-angiotensin-converting-enzyme-inhibitor-and-calcium-channel-bloc-18960https://curecurrent.com/trials/processed-meat-and-brain-regions-related-to-reward-and-addiction-18961https://curecurrent.com/trials/cold-induced-activation-of-brown-adipose-tissue-in-winter-swimmers-18962https://curecurrent.com/trials/sglt-2i-and-arb-combination-therapy-in-patients-with-t2dm-and-nocturnal-hypertension-sacra-study-18963https://curecurrent.com/trials/cold-induced-activation-of-brown-adipose-tissue-in-humans-18964https://curecurrent.com/trials/effect-of-laser-treatment-for-diabetic-retinopathy-on-the-optic-disc-topography-18965https://curecurrent.com/trials/how-diabetic-patient-are-taken-care-in-cardiology-service-actually-18966https://curecurrent.com/trials/metabolic-changes-after-bariatric-surgery-18967https://curecurrent.com/trials/blood-pressure-control-for-type-2-diabetes-18968https://curecurrent.com/trials/attenuating-the-post-operative-insulin-resistance-and-promoting-protein-anabolism-18969https://curecurrent.com/trials/dpp-4-inhibitor-and-serum-bnp-level-of-diabetic-patients-with-congestive-heart-failure-18970https://curecurrent.com/trials/the-potential-of-carnosine-supplementation-in-reducing-the-cardiometabolic-risk-18971https://curecurrent.com/trials/telematic-program-for-the-treatment-of-depression-in-type-1-diabetes-18972https://curecurrent.com/trials/laser-therapy-for-onychomycosis-in-patients-wih-diabetes-at-risk-for-diabetic-foot-complications-18973https://curecurrent.com/trials/large-scale-demonstrator-webportal-diabetes-18974https://curecurrent.com/trials/avandamet-versus-metformin-for-type-2-diabetes-mellitus-18975https://curecurrent.com/trials/increasing-the-effectiveness-of-the-diabetes-prevention-program-18976https://curecurrent.com/trials/effect-of-liraglutide-on-cardiovascular-endpoints-in-diabetes-mellitus-type-2-patients-of-south-asian-descent-18977https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-and-efficacy-of-polyclonal-antibodies-in-simultaneous-pancreas-kidney-transpl-18978https://curecurrent.com/trials/relation-of-epicardial-fat-and-diabetic-nephropathy-in-egyptian-patients-18979https://curecurrent.com/trials/effect-of-long-term-lipoic-acid-treatment-on-endothelial-function-in-patients-with-type-2-diabetes-18980https://curecurrent.com/trials/study-of-anemia-in-chronic-kidney-disease-ckd-among-high-risk-hypertensive-and-diabetic-patients-in-pakistan-18981https://curecurrent.com/trials/smartphone-application-for-type-2-diabetes-18982https://curecurrent.com/trials/insulin-pump-vs-multiple-daily-injections-of-insulin-and-glyco-metabolic-control-in-type-1-diabetic-patients-18983https://curecurrent.com/trials/effect-of-vitamin-b12-supplementation-on-glycaemic-control-in-uncontrolled-hyperhomocysteinemic-type-2-diabetic-patients-18984https://curecurrent.com/trials/efficacy-study-of-water-drinking-on-pkd-progression-18985https://curecurrent.com/trials/safety-and-efficacy-study-of-encapsulated-human-islets-allotransplantation-to-treat-type-1-diabetes-18986https://curecurrent.com/trials/post-marketing-surveillance-pms-study-of-ryzodeg-insulin-degludec-insulin-aspart-in-patients-with-diabetes-mellitus-in-r-18987https://curecurrent.com/trials/clinical-study-to-evaluate-the-bio-psychosocial-impact-of-mobile-app-for-diabetes-type-1-social-diabetes-18988https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-rt-cgm-in-patients-with-type-1-diabetes-at-high-risk-for-low-glucose-values-usin-18989https://curecurrent.com/trials/innovative-stratification-of-arrhythmic-risk-isar-trial-diabetes-mellitus-18990https://curecurrent.com/trials/optimization-of-cardioprotection-in-diabetic-patients-undergoing-cardiac-surgery-18991https://curecurrent.com/trials/prevalence-of-chronic-kidney-disease-ckd-and-risk-factors-in-sub-saharan-africa-18992https://curecurrent.com/trials/the-efficacy-of-sodium-glucose-co-transporter-2-inhibitor-or-dipeptidyl-peptidase-4-inhibitor-in-type-2-diabetes-patient-18993https://curecurrent.com/trials/a-study-measuring-the-effectiveness-of-combined-modulated-ultrasound-and-electric-current-stimulation-as-an-adjunctive-t-18994https://curecurrent.com/trials/cardiovascular-risk-factors-in-patients-with-diabetes-a-prospective-study-in-primary-care-18995https://curecurrent.com/trials/cohort-study-of-pioglitazone-and-bladder-cancer-in-patients-with-type-ii-diabetes-18996https://curecurrent.com/trials/dapagliflozin-in-type-2-diabetes-patients-a-retrospective-cohort-study-from-turkey-18997https://curecurrent.com/trials/prudente-diabetes-prevention-via-exercise-nutrition-and-treatment-18998https://curecurrent.com/trials/cohort-study-of-pioglitazone-and-cancer-incidence-in-participants-with-diabetes-mellitus-18999https://curecurrent.com/trials/epidemiologic-study-of-diabetes-and-cancer-risk-19000